prednisolone has been researched along with Acute Lymphoid Leukemia in 338 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to determine the clinically optimal dose of KRN8602, a new anthracycline derivative, in combination therapy for acute leukemia, we performed a pilot late phase II study in combination with cytarabine (Ara-C) for acute myelogenous leukemia (AML), and with vincristine (VCR) and prednisolone (PSL) for acute lymphocytic leukemia (ALL)." | 5.09 | [Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination]. ( Hiraoka, A; Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K, 1999) |
| " She was diagnosed with myocarditis and successfully treated using prednisolone." | 5.05 | Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review. ( Hiroshima, Y; Kazumoto, H; Kirihara, T; Kitahara, M; Kobayashi, H; Sato, K; Shimizu, K; Shishido, T; Sumi, M; Ueki, T; Uematsu, N, 2020) |
| " Although he was treated with prednisolone and hydroxyurea, marked eosinophilia persisted and lymphoblasts gradually increased in the bone marrow." | 4.78 | Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia. ( Sanada, M; Takai, K, 1991) |
| " The patient had been administered steroid and cyclosporine for chronic graft-versus-host disease." | 3.77 | [Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation]. ( Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F, 2011) |
| " On the contrary, there is only one report of VOD during induction therapy for acute lymphoblastic leukemia in a patient with Marfan syndrome, who was successfully treated with defibrotide [2]." | 3.74 | Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia. ( Diamantidis, MD; Girtovitis, F; Hatzitolios, A; Kaiafa, G; Kontoninas, Z; Ntaios, G; Papadopoulos, A; Saouli, Z; Savopoulos, C, 2008) |
| " The purpose of this study was to assess the incidence of adrenal insufficiency and the time for children with ALL to recover after treatment with the glucorticoids prednisolone or dexamethasone." | 3.72 | Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia. ( Müller, J; Petersen, KB; Rasmussen, M; Schmiegelow, K, 2003) |
| "Serum levels of IgG subclasses were analysed in 15 children with acute lymphoblastic leukemia (ALL) receiving maintenance chemotherapy and 10 children with aplastic anemia and autoimmune diseases receiving prednisolone therapy longer than 2 months (Steroid group)." | 3.68 | [Effects of immunosuppressive chemotherapy on serum levels of IgG subclasses--analysis in children with acute lymphoblastic leukemia and in children with aplastic anemia and autoimmune diseases receiving corticosteroid hormone]. ( Fujieda, M; Hisakawa, H; Kubota, H; Kurashige, T; Matsumoto, K; Wakiguchi, H, 1990) |
| " A population pharmacokinetic model was developed and post hoc area under the curve (AUC) was tested against treatment outcome parameters." | 3.01 | Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response. ( Bierings, MB; de Haas, V; Kaspers, GJL; Mathôt, RAA; Pieters, R; Sassen, SDT; Te Loo, DMWW; Tissing, WJE; van den Bos, C; van der Sluis, IM; Zwaan, CM, 2021) |
| "The outcome for pediatric acute lymphoblastic leukemia (ALL) patients who relapse is dismal." | 2.80 | MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. ( Bhatla, T; Bitterman, DS; Bourgeois, W; Bride, K; Burleson, TM; Carroll, WL; Dandekar, S; de Rijk, SR; Delgado-Martin, C; Evensen, NA; Fosmire, S; Garabedian, MJ; Gearheart, CM; Hermiston, ML; Hunger, SP; Jones, CL; Loh, ML; Madhusoodhan, PP; Müschen, M; Pais, F; Park, E; Porter, CC; Raetz, EA; Teachey, DT; Waanders, AJ; Wang, J; Zhang, J, 2015) |
| "A total of 1947 patients with acute lymphoblastic leukemia were randomized." | 2.79 | Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. ( Benoit, Y; Bertrandfor, Y; Cavé, H; Dastugue, N; De Moerloose, B; Domenech, C; Ferster, A; Girard, S; Lutz, P; Mazingue, F; Millot, F; Munzer, M; Philippet, P; Plantaz, D; Plat, G; Röhrlich, P; Sirvent, N; Suciu, S; Uyttebroeck, A; Yakouben, K, 2014) |
| "Infants (<366 days of age) with acute lymphoblastic leukemia (ALL) have a poor prognosis." | 2.77 | Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407. ( Camitta, B; Carroll, WL; Devidas, M; Dreyer, ZE; Hilden, JM; Hunger, S; Jones, TL; Salzer, WL; Winick, N, 2012) |
| "Four clinically important acute lymphoblastic leukemia cell lines, three PRED-sensitive (697, Sup-B15, and RS4;11) and one PRED-resistant (REH) were studied." | 2.76 | BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia. ( Ariffin, H; Chew, FT; Jiang, N; Kham, SK; Koh, GS; Lim, JY; Yeoh, AE, 2011) |
| "The current randomized comparisons in childhood ALL indicated a statistically significant and clinically important decrease in rate of isolated central nervous system (CNS) relapses and an increase in event-free survival (EFS) with DXM." | 2.75 | Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia? ( Cai, X; Liu, X; Sun, Z; Wu, J; Zheng, C; Zhu, W, 2010) |
| "Adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma were randomized to receive, as part of their induction therapy on days 1-8 and 15-22, either dexamethasone 8 mg/m(2) or prednisolone 60 mg/m(2)." | 2.75 | Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group. ( Amadori, S; Berneman, Z; Bron, D; De Bock, R; de Witte, T; Feremans, W; Fillet, G; Gilotay, C; Jaksic, B; Labar, B; Marie, JP; Mistrik, M; Muus, P; Nemet, D; Sinnige, H; Suciu, S; Vreugdenhil, G; Willemze, R, 2010) |
| "Availability of measurement of minimal residual disease (MRD) at an early time point with a reduced-cost method is of clinical relevance." | 2.74 | Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. ( Arico, M; Basso, G; Benetello, A; Biondi, A; Buldini, B; Conter, V; Dworzak, MN; Gaipa, G; Maglia, O; Masera, G; Ratei, R; Silvestri, D; Valsecchi, MG; Veltroni, M, 2009) |
| "Our study included 37 patients with acute lymphoblastic leukemia (ALL) and 11 patients with Morbus Hodgkin (MH) disease, who were treated with high-dose glucocorticoid therapy, and 26 control patients with other types of malignancies." | 2.73 | Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers. ( Aschenbrenner, C; Baumgartner, M; Bieglmayer, C; Dworzak, M; Felder-Puig, R; Gadner, H; Koper, JW; Nasel, C; Ortner, M; Panzer-Grümayer, ER; Scherzer, C; Steinberger, K; Tissing, WJ; Topf, R; Voigtländer, T, 2007) |
| " There is increasing evidence that, even in equipotent dosage for glucocorticoid effect, dexamethasone has enhanced lymphoblast cytotoxicity and penetration of the central nervous system (CNS) compared with prednisolone." | 2.71 | Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. ( Eden, TO; Kinsey, SE; Lilleyman, J; Mitchell, CD; Richards, SM; Vora, A, 2005) |
| "A two-compartment pharmacokinetic model was used to describe data from 23 children with ALL (aged 2-15 years)." | 2.71 | Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. ( Jusko, WJ; Petersen, KB; Rasmussen, M; Schmiegelow, K, 2003) |
| "The leptin : SHBG ratio increase indicates that this may be a novel and sensitive biochemical marker of metabolic change." | 2.71 | Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. ( Ahmed, SF; Hughes, IA; Tucker, P; Wallace, AM; Williams, DM, 2003) |
| "We investigated whether there was a dose-response relationship for the use of corticosteroids in childhood acute lymphoblastic leukemia (ALL)." | 2.70 | Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. ( Chilton, D; Cohen, HJ; Gelber, RD; Sallan, SE; Schwartz, CL; Thompson, EB; Young, ML, 2001) |
| "In a prior study, primary resistant acute lymphoblastic leukemia (RES-ALL) was observed in 11 of 176 (6%) adult patients treated with a four drug regimen (IVAP), its incidence being higher in T-cell or Philadelphia (Ph) chromosome/BCR-ABL rearrangement positive ALL cases with a blast cell count >25x10(9)/L (RES-ALL rate 19%, p=0." | 2.69 | Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinic ( Barbui, T; Bassan, R; Casula, P; Corneo, G; Coser, P; Fabris, P; Izzi, T; Lambertenghi-Deliliers, G; Lerede, T; Morandi, S; Pogliani, E; Rossi, G; Vespignani, M, 1999) |
| "Patients with acute lymphocytic leukemia (ALL) and those with lymphoblastic lymphoma (LBL) have overlapping clinical and immunophenotypic features and they have been treated with the same or very similar chemotherapy regimens." | 2.69 | Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group. ( Abe, T; Aoki, I; Araki, K; Deura, K; Fukuda, H; Fukuhara, S; Hotta, T; Kobayashi, T; Konda, S; Kozuru, M; Matsumoto, M; Mikuni, C; Nagai, M; Niimi, M; Oyama, A; Sai, T; Shimoyama, M; Shirakawa, S; Tajima, K; Tobinai, K; Toki, H; Yamaguchi, N, 1999) |
| "Hyperglycemia in children with acute lymphoblastic leukemia (ALL) has been well documented in the literature." | 2.69 | Clinical value of glycated hemoglobin and fructosamine in the long-term glycemic control of children with acute lymphoblastic leukemia. ( Ozbek, N; Yalçin, SS; Yetgin, S, 1998) |
| "In children with acute lymphoblastic leukemia (ALL), the level of minimal residual disease (MRD) at the end of induction strongly predicts outcome, presumably because it measures both drug sensitivity and the number of leukemic cells requiring elimination." | 2.68 | Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. ( Bradstock, K; Brisco, J; Enno, A; Hughes, E; McCaul, K; Morley, AA; Neoh, SH; Sykes, PJ; Szer, J, 1996) |
| "Idarubicin was preferred to other anthracyclines because of its shorter time to response." | 2.68 | Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia. ( Barbui, T; Bassan, R; Buelli, M; D'Emilio, A; Di Bona, E; Lerede, T; Pogliani, E; Rambaldi, A; Rodeghiero, F; Rossi, G; Viero, P, 1996) |
| "Twelve adult patients with non-leukaemic lymphoblastic lymphoma were treated with combination chemotherapy and central nervous system prophylaxis according to the protocol developed at Stanford University." | 2.67 | Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol. ( Mead, GM; Sweetenham, JW; Whitehouse, JM, 1992) |
| "The treatment of children with acute lymphoblastic leukemia was conducted with the use of 06-Paris-LA-66 program modified by the authors." | 2.67 | [Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia]. ( Kovrigina, TI; Mendeleev, IM; Polezhaev, IuN, 1991) |
| "Sixty-one consecutive patients with acute lymphoblastic leukemia (ALL) (B-ALL excluded) were treated with the protocol described by Hoelzer et al." | 2.67 | High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study. ( Bettelheim, P; Geissler, K; Jäger, U; Knöbl, P; Kyrle, PA; Laczika, K; Mitterbauer, G; Neumann, E; Scherrer, R; Schneider, B, 1994) |
| "A total of 42 adults with acute lymphoblastic leukemia were treated with an aggressive induction/consolidation chemotherapy (MCP-841) between June 1986 and December 1991." | 2.67 | Adult acute lymphoblastic leukemia: results of an aggressive regimen in India. ( Advani, IM; Gopal, R; Nadkarni, K; Pai, S; Pai, V; Parikh, P; Raje, N; Saikia, T; Vaidya, S, 1994) |
| "Prednisolone is a corticosteroid and one of the most important agents in the treatment of acute lymphoblastic leukemia." | 2.66 | Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update. ( Adamaki, M; Hatziagapiou, K; Lambrou, GI; Vlahopoulos, S, 2020) |
| "We report a case of de novo acute lymphoblastic leukemia with tandem amplification of the AML1 gene located in a chromosome marker that originated from chromosome 21 and a long event-free survival." | 2.42 | AML1 amplification in a child with acute lymphoblastic leukemia. ( Alvarez, Y; Bastida, P; Caballín, MR; Coll, MD; Ortega, JJ, 2003) |
| "Even though acute lymphoblastic leukemia (ALL) responds well to chemotherapy, relapse remains the major problem." | 2.41 | Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. ( Botsonis, A; Moschovi, M; Papadopoulou, AL; Tsangaris, GT; Tzortzatou-Stathopoulou, F, 2001) |
| "Congestive heart failure was observed in only 2." | 2.41 | Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. ( Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F, 2001) |
| "This favorable response with the ANLL-9205 protocol was mainly to high induction rate of patients with the M4 and M5 subtypes, as compared to those in the previous two protocols." | 2.40 | [Recent advances on the treatment of acute childhood leukemia]. ( Fujimoto, T, 1997) |
| "However, the results of acute lymphoblastic leukemia in the JALSG ALL 87 study were not satisfactory; 84% CR in 116 adults and only 24% 6-year DFS." | 2.39 | [Progress of chemotherapy in adult acute leukemia]. ( Ohno, R, 1995) |
| "We report here a patient with acute lymphoblastic leukemia (ALL) in whom hypofibrinogenemia developed during chemotherapy." | 2.38 | [Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia]. ( Baba, Y; Fujieda, H; Hojo, H; Ohyashiki, JH; Ohyashiki, K; Toyama, K, 1989) |
| "Prednisolone is a corticosteroid and one of the most important agents in the treatment of ALL." | 1.62 | Early and Very Early GRIM19 and MCL1 Expression Are Correlated to Late Acquired Prednisolone Effects in a T-Cell Acute Leukemia Cell Line. ( Adamaki, M; G, L; Geronikolou, SA; Hatziagapiou, K; Tsartsalis, AN; Vlahopoulos, S, 2021) |
| "Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are more likely to have chemotherapy-related complications than children." | 1.62 | Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy. ( Hori, D; Kobayashi, K; Kobayashi, R; Kodama, K; Matsushima, S; Sano, H; Suzuki, D; Yanagi, M, 2021) |
| "Prednisolone has been used frequently in the treatment of acute lymphoblastic leukemia." | 1.62 | Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia. ( Aksoylar, S; Alpay, A; Bagca, BG; Cogulu, O; Durmaz, B; Gunduz, C; Susluer, SY, 2021) |
| "In childhood acute lymphoblastic leukemia, high treatment-related mortality, especially in the induction phase of treatment, is a major challenge for developing countries." | 1.56 | Prednisolone Prophase for a Week Versus Upfront Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia: An Analysis With Reference to Induction Mortality in a Developing Country. ( Ashraf, S; Butt, Z; Jabbar, N; Mansoor, N; Maqsood MSc, S; Nadeem, K, 2020) |
| "acute lymphoblastic leukemia-type chemotherapy that incorporated high-dose cytarabine was effective in achieving an minimal residual disease-negativity rate of 69% in evaluated patients, which was also predictive of better outcome." | 1.56 | Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India. ( Banavali, S; Gujral, S; Myint, HH; Narula, G; Patkar, N; Prasad, M; Subramanian, P; Tandon, S; Tembhare, P, 2020) |
| "Concerning hematological disorders, Sweet syndrome often presents in patients with myeloid diseases, but it is rarely observed in patients with lymphoid diseases." | 1.51 | [Recurring Sweet syndrome in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia]. ( Aoki, T; Ishihara, D; Kamimura, T; Umeno, T; Urata, S, 2019) |
| "Multivariate analysis revealed that minimal residual disease positive and time interval between induction IA and Protocol M of more than 70 days were independent adverse factors for EFS and OS." | 1.51 | Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study. ( Cai, X; Chen, X; Li, C; Liang, Y; Wang, H; Xia, Z, 2019) |
| "Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43." | 1.48 | Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan. ( Anwar, S; Faizan, M; Khan, S, 2018) |
| "For children with precursor B (pre-B) acute lymphoblastic leukemia (ALL) with TCF3-PBX1 fusion gene, their prognosis has been a controversial topic." | 1.42 | Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol. ( Chai, YH; Liang, Y; Pan, J; Pang, L; Wang, JR; Zhao, WL, 2015) |
| "Imatinib mesylate has dramatically improved the outcome of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph* ALL) and is now included as first-line therapy." | 1.42 | Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. ( Fukushima, H; Fukushima, T; Kobayashi, C; Nanmoku, T; Sakai, A; Satomi, K; Sumazaki, R; Suzuki, R; Tagawa, M, 2015) |
| "To compare, for the first time, the in vitro antileukemic activity of prednisolone alone to that of a combination of prednisolone and dexamethasone using dexamethasone at a very low and presumably safe dosage (1/50 w/w)." | 1.40 | Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia. ( Blazek, B; Bubanska, E; Burianova, R; Dzubak, P; Hajduch, M; Hak, J; Kaiserova, E; Konecny, P; Mihal, V; Novak, Z; Pospisilova, D; Radova, L; Salkova, S; Spenerova, M; Srovnal, J; Stary, J; Timr, P; Votava, T, 2014) |
| "We found that nasolacrimal duct obstruction did not improve with medical treatment but ptosis and esotropia improved with pyridoxine and pyridostigmine treatment during that period." | 1.39 | Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia. ( Burakgazi-Dalkilic, E; Esmer, O; Karadag, R; Oner, AF; Soylu, E, 2013) |
| "MLL-rearranged infant acute lymphoblastic leukemia (ALL) (<1 year of age) are frequently resistant to glucocorticoids, like prednisone and dexamethasone." | 1.39 | Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( Mimoso Pinhanços, S; Pieters, R; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW, 2013) |
| "At 4 years old he was diagnosed with acute lymphoblastic leukemia and underwent bone marrow transplantation." | 1.38 | Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation. ( Furuya, A; Ida, K; Igarashi, T; Koh, K; Miura, K; Sekine, T; Takamizawa, M; Takita, J; Terashima, H, 2012) |
| "MLL-rearranged acute lymphoblastic leukemia (ALL) in infants is characterized by a poor clinical outcome and resistance to glucocorticoids (for example, prednisone and dexamethasone)." | 1.38 | Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( de Boer, J; Hulleman, E; Pieters, R; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW; Williams, O, 2012) |
| "Spinal cord compression is a rare complication of acute lymphoblastic leukemia (ALL)." | 1.37 | Spinal cord compression by epidural involvement over 21 vertebral levels in acute lymphoblastic leukemia. ( Fukaya, T; Isome, K; Iwata, A; Matsubara, K; Nigami, H; Taki, T; Taniwaki, M; Wada, T; Yura, K, 2011) |
| "A patient with relapsed Acute Lymphoblastic Leukemia and recurrent pericardial effusion presented." | 1.37 | Intrapericardial steroid treatment for recurrent pericardial effusion in a patient with acute lymphoblastic Leukaemia. ( Hatib, I; Lorber, A; Mainzer, G; Zaidman, I, 2011) |
| "The renal biopsy showed type I membranoproliferative glomerulonephritis." | 1.36 | Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. ( Chang, YS; Chung, S; Kim, B; Kim, JY; Lee, MY; Park, CW, 2010) |
| "Obesity is increasingly prevalent in affluent societies and portends considerable morbidity." | 1.36 | Growth in children with acute lymphoblastic leukemia during treatment. ( Barr, RD; Collins, L; Nayiager, T; Pollock, BH; Zarzabal, LA, 2010) |
| "Good prednisolone response was observed in 82% of cases." | 1.35 | Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. ( Bajel, A; Chandy, M; George, B; Kavitha, ML; Mathews, V; Srivastava, A; Viswabandya, A, 2008) |
| "Chemotherapy-induced oral mucositis is a frequent therapeutic challenge in cancer patients." | 1.35 | Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. ( Figliolia, SL; Lauris, JR; Maurício, AR; Mello de Andrea, ML; Oliveira, DT; Pereira, MC, 2008) |
| "Treatment of prednisolone-resistant Jurkat and Molt4 cells with 2-deoxy-D-glucose (2-DG), lonidamine (LND), or 3-bromopyruvate (3-BrPA) increased the in vitro sensitivity to glucocorticoids, while treatment of the prednisolone-sensitive cell lines Tom-1 and RS4; 11 did not influence drug cytotoxicity." | 1.35 | Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. ( Broekhuis, MJ; Den Boer, ML; Evans, WE; Holleman, A; Hulleman, E; Kazemier, KM; Pieters, R; Rudin, CM; VanderWeele, DJ, 2009) |
| "Prednisolone resistance was higher in SMARCA4 shRNA-transfected Jurkat cells (drug concentration lethal to 50% of the leukemia cells [LC(50)] = 277 microM) than in control shRNA-transfected cells (LC(50) = 174 microM, difference = 103 microM, 95% confidence interval of the difference = 100 to 106 microM; P < ." | 1.35 | The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. ( Assem, M; Cheng, C; Cheok, MH; Den Boer, ML; Evans, WE; Panetta, JC; Paugh, SW; Pei, D; Pieters, R; Pottier, N; Relling, MV; Yang, W, 2008) |
| " All six patients received prophylactic cranial irradiation with a dosage of 18 or 24 Gy." | 1.34 | Moyamoya syndrome following childhood acute lymphoblastic leukemia. ( Hanada, R; Ikuta, K; Ishimoto, K; Kaneko, T; Kikuchi, A; Maeda, M; Okimoto, Y; Tsuchida, M, 2007) |
| "The treatment outcome of children with acute lymphoblastic leukemia improved remarkably over the last decades." | 1.33 | [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary]. ( Bartyik, K; Békési, A; Galántai, I; Jakab, Z; Kajtár, P; Kiss, C; Kovács, G; Magyarosy, E; Masát, P; Müller, J; Nagy, K; Rényi, I, 2005) |
| "Thalidomide is a drug with anti-angiogenic, anti-inflammatory, immunomodulatory and anti-cancer properties that were found to inhibit the production of TNF-alpha in vitro, stimulate reactive oxygen species production, and inhibit VEGFR in acute leukemias." | 1.33 | Ex vivo activity of thalidomide in childhood acute leukemia. ( Czyzewski, K; Styczynski, J; Wysocki, M, 2006) |
| "Superior sagittal sinus thrombosis (SSST) has been reported to be caused by coagulopathy following oral contraceptive therapy, DIC, infection around the sinus, compression from a tumor, infiltration of tumor, and an inherited deficiency of proteins C and S, but SSST associated with hematological malignancies and L-asparaginase (L-Asp) therapy is rare." | 1.33 | [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia]. ( Iijima, K; Iki, S; Kida, M; Nakasone, H; Taoka, K; Urabe, A; Usuki, K; Yoshimi, A, 2006) |
| "Cellular sensitivity in acute lymphoblastic leukemia (ALL) was higher than in acute myeloid one (AML), while T-line ALL cells were more sensitive to dexamethasone than those of B-line." | 1.33 | [Drug sensitivity of tumor cells in varieties of acute childhood leukemia]. ( Belevtsev, MV; Buglova, SE; Shman, TV, 2005) |
| "GC resistance in childhood ALL cannot be attributed to an inability of resistant cells to up-regulate the expression of the GR upon GC exposure, nor to differences in GR promoter usage (at baseline and upon GC exposure)." | 1.33 | Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. ( Brinkhof, B; Broekhuis, MJ; den Boer, ML; Meijerink, JP; Menezes, RX; Pieters, R; Tissing, WJ, 2006) |
| "No increased frequency of infection was seen for the children with genotypes encoding serum low levels of MBL." | 1.33 | Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency. ( Andreassen, B; Garred, P; Lausen, B; Madsen, HO; Schmiegelow, K, 2006) |
| "Prednisolone treated patients had an increased percentage body fat (SDS +0." | 1.33 | No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. ( de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Krenning, EP; Pieters, R; van Beek, RD; van den Heuvel-Eibrink, MM; van der Sluis, IM, 2006) |
| "Acute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of children, but the cause of treatment failure in the remaining patients is unknown." | 1.33 | Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. ( Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Lugthart, S; Pieters, R; Pui, CH; Relling, MV; Yang, W, 2005) |
| "Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy in approximately 80 percent of patients." | 1.32 | Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. ( Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Kazemier, KM; Pei, D; Pieters, R; Pui, CH; Relling, MV; Veerman, AJ; Yang, W, 2004) |
| "A 9-year-old patient with leukemia received oral prednisolone at a dosage of 2." | 1.32 | Intraocular pressure profile of a child on a systemic corticosteroid. ( Chik, KW; Lam, DS; Li, RT; Ng, JS; Tham, CC, 2004) |
| "t(12;21)(p1 3;q22), the most frequent chromosomal translocation found in childhood acute lymphoblastic leukemia (ALL), occurs in approximately 25% of B-lineage ALL cases and has been claimed to carry a good prognosis." | 1.32 | Post-induction residual disease in translocation t(12;21)-positive childhood ALL. ( Clausen, N; Jonmundsson, GK; Madsen, HO; Nyvold, C; Ryder, LP; Schmiegelow, K; Seyfarth, J; Wesenberg, F, 2003) |
| "A 26-year-old male with acute lymphoblastic leukemia (ALL) in its second complete remission received an unrelated bone marrow transplantation (UBMT) following cyclophosphamide plus total body irradiation conditioning." | 1.31 | A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. ( Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A, 2002) |
| "Most prognostic factors in childhood acute lymphoblastic leukemia (ALL) are informative for groups of patients, whereas new approaches are needed to predict the efficacy of chemotherapy for the individual patient." | 1.31 | Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. ( Kaspers, GJ; Knabe, N; Madsen, HO; Nyvold, C; Pieters, R; Rottier, MM; Ryder, LP; Schmiegelow, K; Seyfarth, J; Svejgaard, A, 2001) |
| "The prognosis for DS acute myeloid leukemia (AML) is better than for non-DS AML, but the clinical outcome of DS acute lymphoblastic leukemia (ALL) is equal to that of non-DS ALL." | 1.31 | Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. ( Creutzig, U; de Vries, E; Hählen, K; Huismans, DR; Janka-Schaub, GE; Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ; Zwaan, CM, 2002) |
| "Treatment failure in newly diagnosed childhood ALL can be predicted based on cellular drug resistance data." | 1.30 | In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. ( Kaspers, GJ; Pieters, R; Smets, LA; Van Der Does-Van Den Berg, A; Van Wering, ER; Van Zantwijk, CH; Veerman, AJ, 1997) |
| "There were 55 patients with acute myelogenous leukemia (AML), 13 acute lymphoblastic leukemia (ALL) and 8 AML from myelodysplastic syndrome (MDS/AML)." | 1.30 | [Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia]. ( Amemiya, Y; Furukawa, Y; Hoshino, M; Imagawa, S; Izumi, T; Kawano, C; Kirito, K; Komatsu, N; Kuribara, R; Miura, Y; Miyazato, A; Muroi, K; Omine, K; Otsuki, T; Shimizu, R; Suzuki, T; Tabata, M; Takahashi, H; Takatoku, M; Terui, Y; Tomizuka, H; Toshima, M; Tsunoda, J; Uchida, M; Yoshida, M, 1998) |
| "Acute lymphoblastic leukemia (L3) was initially diagnosed because of poor staining of alpha-naphtyl butylate esterase and induction chemotherapy with the LVP regimen (L-asparaginase 5,000 U/m2 day 8-21, vincristine 1." | 1.30 | [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement]. ( Fujita, H; Kobayashi, S; Kodama, F; Koharazawa, H; Maruta, A; Okubo, T; Tomita, N; Yamamoto, T, 1997) |
| " After initial chemotherapy, he received intravenous methotrexate (total dosage 1,035 mg), intrathecal methotrexate (total dosage 221 mg), and whole brain irradiation (2,400 cGy)." | 1.29 | Lenńox-Gastaut syndrome associated with leukoencephalopathy. ( Ikuta, H; Mitsufuji, N; Sawada, T; Yoshioka, H, 1996) |
| "Ten months after referral, she developed acute lymphoblastic leukemia (FAB classification; L1)." | 1.29 | Acute lymphoblastic leukemia in Ehlers-Danlos syndrome. ( Asano, T; Yamamoto, M, 1996) |
| " This finding may serve to guide the selection of dexamethasone dosage in the treatment of ALL." | 1.29 | Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. ( Campana, D; Coustan-Smith, E; Evans, WE; Ito, C; Mahmoud, H; McNinch, L; Pui, CH, 1996) |
| "Results of clinical studies of childhood acute lymphoblastic leukemia (ALL) suggested that DXM is more potent relative to PRD than assumed." | 1.29 | Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. ( Kaspers, GJ; Lomecky, M; Pieters, R; Popp-Snijders, C; Swinkels, LM; Van Wering, ER; Van Zantwijk, CH; Veerman, AJ, 1996) |
| "From 1975 to 1989, 71 acute lymphoblastic leukemia patients aged 15 to 81 years (median 46 years) were treated at Jichi Medical School." | 1.29 | [Treatment of 71 adult acute lymphoblastic leukemia]. ( Akutsu, M; Furukawa, Y; Imagawa, S; Iwama, A; Komatsu, N; Kurata, H; Suzuki, T; Tsunoda, J; Tsunoda, S; Yoshida, M, 1993) |
| "Late-relapse was more frequently observed in boys (37." | 1.29 | [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia]. ( Fujioka, K; Funabiki, T; Hanzawa, N; Ikuta, K; Kai, S; Kajigaya, Y; Okuyama, T; Sekiguchi, H; Sumita, H; Takahashi, H, 1993) |
| "When patients with common acute lymphoblastic leukemia (cALL) and acute myeloblastic leukemia (AML) were treated with prednisolone (60 mg/m2/day, p." | 1.29 | Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo. ( Adachi, S; Akiyama, Y; Hirota, H; Kubota, M; Kuwakado, K; Matsubara, K; Mikawa, H; Wakazono, Y, 1994) |
| " The type of interaction was different between patients, and depends on the drug combination and concentrations." | 1.29 | Drug combination testing in acute lymphoblastic leukemia using the MTT assay. ( Hählen, K; Kaspers, GJ; Pieters, R; Van Wering, ER; Van Zantwijk, I; Veerman, AJ, 1995) |
| "Information about elderly patients with acute lymphoblastic leukemia is scarce." | 1.28 | [Treatment of elderly patients with hematological malignancies]. ( Mizoguchi, H; Saito, H, 1992) |
| "The complete remission (CR) rate of ANLL was 90." | 1.28 | [Evaluation of 58 patients with acute leukemia]. ( Sasaki, A; Tsukaguchi, M, 1992) |
| "After 5 months, diagnosis of acute lymphocytic leukemia (ALL) was made on the evidence that lymphoblasts were found in PB (1%) and in BM (98%)." | 1.28 | [Acute lymphocytic leukemia (L1) preceded by hypercalcemia]. ( Ishizaki, J; Kawano, K; Maeda, K; Maruyama, H; Matsuoka, H; Tamaki, N; Tsuda, K; Uno, H; Yamashita, R, 1992) |
| "For prednisolone there was a significant worsening of the prognosis (p less than 0." | 1.28 | Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. ( Hählen, K; Huismans, DR; Loonen, AH; Pieters, R; van der Does-van den Berg, A; van Wering, ER; Veerman, AJ, 1991) |
| "Twenty-nine adult patients with acute lymphocytic leukemia (ALL) were treated with combination chemotherapy consisting of behenoyl-ara-C, adriamycin, cyclophosphamide, vindesine and prednisolone (BHAC-ACVP regimen)." | 1.28 | [A study of combination chemotherapy (BHAC-ACVP) for adult acute lymphocytic leukemia. Hanshin Co-operative Study Group of Hematological Malignancies]. ( Horiuchi, A; Kageyama, T; Kakishita, E; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Tatsumi, N; Yasunaga, K, 1992) |
| " An animal model is presented to assess these adverse effects on growth." | 1.28 | An animal model to study toxicity of central nervous system therapy for childhood acute lymphoblastic leukemia: effects on growth and craniofacial proportion. ( Howes, A; Mullenix, PJ; Schunior, A; Tarbell, NJ; Tassinari, MS; Zengel, AE, 1990) |
| "A 38-year-old female with acute lymphoblastic leukemia developed monoplegia of the left upper extremity following chemotherapy for remission induction consisting of vincristine, prednisolone, cyclophosphamide, adriamycin and methotrexate." | 1.28 | [Transient dysfibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia]. ( Harada, M; Hayashi, S; Kubota, T; Nagafuchi, S; Niho, Y; Ohtsuka, T; Okamura, T; Shibuya, T, 1990) |
| "The use of azathioprine in ulcerative colitis is unclear." | 1.28 | The role of azathioprine in the management of ulcerative colitis. ( Axon, AT; Burke, DA; Foster, PN; Johnston, D; Lobo, AJ, 1990) |
| "Pretreatment with prednisolone was started as therapy for leukemia, and 2 days later, the patient underwent surgery." | 1.28 | Intestinal obstruction at the onset of acute lymphoblastic leukemia in a child. ( Ballati, G; Cozzi, F; Digilio, G; Iacobini, M; Lemmo, M; Multari, G; Roggini, M; Sirignano, A; Werner, B, 1990) |
| "An 11 year-old girl was diagnosed as acute lymphoblastic leukemia (ALL) on November 26th 1979 and was induced into complete remission with vincristine and prednisolon." | 1.28 | [Long-term surviving child with acute lymphoblastic leukemia complicated with legionellosis]. ( Nakura, E; Ohno, R; Saito, H; Tanabe, N, 1990) |
| "Eighteen adults with acute lymphoblastic leukemia (ALL) including 14 previously untreated and 4 relapsed cases were treated with individualized and intensified induction and post-remission therapy." | 1.28 | [Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy]. ( Ito, T; Komatsu, M; Saito, Y; Takahashi, H; Toyota, T; Uzuka, Y, 1990) |
| "Since April, 1978 to October, 1988, 66 acute lymphocytic leukemia (ALL) patients aged 15 to 79 (21 L1, 43 L2, 2 L3/6 Ph1+) were treated with 3 different therapeutic protocols." | 1.28 | [Treatment of acute lymphocytic leukemia in adult]. ( Hayashi, N; Inagaki, N; Matuzaki, T; Nakada, H; Nishimura, M; Nonaka, K; Osada, K; Sekito, N; Takahashi, I; Takeuchi, M, 1989) |
| " For total prednisolone, the mean elimination half-life was relatively short (1." | 1.28 | Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia. ( Blackburn, M; Choonara, I; Lewis, I; Rayner, P; Wheeldon, J, 1989) |
| "They were ALL(6), ANLL(8), CML(1) and NHL(1)." | 1.27 | [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia]. ( Hatae, Y; Hatayama, Y; Nakadate, H; Takeda, T, 1988) |
| "20 consecutive adult patients with acute lymphoblastic leukemia were treated with an intense induction regimen including vincristine, doxorubicin, prednisolone, L-asparaginase and cyclophosphamide." | 1.27 | Aggressive treatment improves survival in adult acute lymphoblastic leukemia. ( Killander, A; Simonsson, B; Smedmyr, B; Sundström, C, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (4.44) | 18.7374 |
| 1990's | 122 (36.09) | 18.2507 |
| 2000's | 105 (31.07) | 29.6817 |
| 2010's | 78 (23.08) | 24.3611 |
| 2020's | 18 (5.33) | 2.80 |
| Authors | Studies |
|---|---|
| Durmaz, B | 1 |
| Bagca, BG | 1 |
| Cogulu, O | 1 |
| Susluer, SY | 1 |
| Alpay, A | 1 |
| Aksoylar, S | 1 |
| Gunduz, C | 1 |
| Moriya, K | 1 |
| Imamura, T | 2 |
| Katayama, S | 1 |
| Kaino, A | 1 |
| Okamoto, K | 2 |
| Yokoyama, N | 1 |
| Uemura, S | 1 |
| Kitazawa, H | 1 |
| Sekimizu, M | 1 |
| Hiramatsu, H | 1 |
| Usami, I | 1 |
| Ishida, H | 1 |
| Hasegawa, D | 5 |
| Hama, A | 1 |
| Moriya-Saito, A | 2 |
| Sato, A | 2 |
| Sasahara, Y | 1 |
| Suenobu, S | 1 |
| Horibe, K | 3 |
| Hara, J | 2 |
| G, L | 1 |
| Adamaki, M | 2 |
| Hatziagapiou, K | 2 |
| Geronikolou, SA | 1 |
| Tsartsalis, AN | 1 |
| Vlahopoulos, S | 3 |
| Sbirkov, Y | 1 |
| Vergov, B | 1 |
| Dzharov, V | 1 |
| Schenk, T | 1 |
| Petrie, K | 1 |
| Sarafian, V | 1 |
| Nekoeian, S | 1 |
| Ferdowsian, S | 1 |
| Asgari, Y | 1 |
| Azizi, Z | 1 |
| Sawada, M | 1 |
| Takachi, T | 1 |
| Watanabe, K | 2 |
| Tsuchiya, Y | 1 |
| Nishimura, K | 1 |
| Hotta, Y | 1 |
| Sato, M | 1 |
| Sumi, M | 1 |
| Kitahara, M | 1 |
| Shishido, T | 1 |
| Kazumoto, H | 1 |
| Uematsu, N | 1 |
| Kirihara, T | 1 |
| Sato, K | 1 |
| Ueki, T | 1 |
| Hiroshima, Y | 1 |
| Shimizu, K | 1 |
| Kobayashi, H | 2 |
| Jabbar, N | 1 |
| Mansoor, N | 1 |
| Nadeem, K | 1 |
| Maqsood MSc, S | 1 |
| Butt, Z | 1 |
| Ashraf, S | 1 |
| Sai, S | 2 |
| Esteves, C | 1 |
| Kelly, V | 1 |
| Sakaguchi, K | 2 |
| McAndrew, R | 1 |
| Chudleigh, S | 1 |
| Spence, A | 1 |
| Gibson, B | 5 |
| Thomas, A | 1 |
| Chapman, KE | 2 |
| Sawaki, A | 1 |
| Miyazaki, K | 1 |
| Yamaguchi, M | 1 |
| Takeuchi, T | 1 |
| Kobayashi, K | 2 |
| Imai, H | 1 |
| Tawara, I | 1 |
| Ono, R | 1 |
| Nosaka, T | 1 |
| Katayama, N | 1 |
| Lambrou, GI | 2 |
| Ganbarjeddi, S | 1 |
| Azimi, A | 5 |
| Zadi Heydarabad, M | 4 |
| Hemmatzadeh, M | 1 |
| Mohammadi, S | 1 |
| Mousavi Ardehaie, R | 1 |
| Zamani, M | 1 |
| Baharaghdam, S | 1 |
| Esmaeili, S | 1 |
| Ghasemi, A | 2 |
| Saburi, M | 1 |
| Ogata, M | 2 |
| Soga, Y | 1 |
| Itani, K | 1 |
| Kohno, K | 1 |
| Nakayama, T | 1 |
| Myint, HH | 1 |
| Tandon, S | 1 |
| Narula, G | 1 |
| Prasad, M | 1 |
| Subramanian, P | 1 |
| Patkar, N | 1 |
| Tembhare, P | 1 |
| Gujral, S | 1 |
| Banavali, S | 1 |
| Matsushima, S | 1 |
| Kobayashi, R | 1 |
| Sano, H | 3 |
| Hori, D | 1 |
| Yanagi, M | 1 |
| Kodama, K | 1 |
| Suzuki, D | 1 |
| Seetharam, S | 2 |
| Thankamony, P | 2 |
| Gopakumar, KG | 2 |
| Nair, RA | 1 |
| Jacob, PM | 1 |
| Jagathnath Krishna, KM | 1 |
| Rajeswari, B | 2 |
| Nair, M | 2 |
| Guruprasad, CS | 1 |
| Prasanth, VR | 1 |
| Sassen, SDT | 1 |
| Mathôt, RAA | 1 |
| Pieters, R | 35 |
| de Haas, V | 1 |
| Kaspers, GJL | 1 |
| van den Bos, C | 1 |
| Tissing, WJE | 1 |
| Te Loo, DMWW | 1 |
| Bierings, MB | 1 |
| van der Sluis, IM | 2 |
| Zwaan, CM | 2 |
| Innes, AJ | 1 |
| Mullish, BH | 1 |
| Fernando, F | 1 |
| Adams, G | 1 |
| Marchesi, JR | 1 |
| Apperley, JF | 1 |
| Brannigan, E | 1 |
| Davies, F | 1 |
| Pavlů, J | 1 |
| Jiang, J | 2 |
| Yin, XY | 1 |
| Song, XW | 1 |
| Xie, D | 1 |
| Xu, HJ | 1 |
| Yang, J | 1 |
| Sun, LR | 1 |
| Rensen, N | 2 |
| Gemke, RJ | 3 |
| van Dalen, EC | 3 |
| Rotteveel, J | 3 |
| Kaspers, GJ | 14 |
| Fujimaki, K | 2 |
| Hattori, Y | 2 |
| Nakajima, H | 1 |
| Faizan, M | 1 |
| Anwar, S | 1 |
| Khan, S | 1 |
| Nikasa, M | 1 |
| Vatanmakanian, M | 1 |
| Farshdousti Hagh, M | 1 |
| Mochizuki, K | 2 |
| Kobayashi, S | 3 |
| Ohara, Y | 2 |
| Ito, M | 4 |
| Waragai, T | 2 |
| Takahashi, N | 2 |
| Ikeda, K | 2 |
| Ohto, H | 1 |
| Kikuta, A | 4 |
| Chandar, R | 1 |
| Appanraj, P | 1 |
| Cs, G | 1 |
| Khanzadeh, T | 1 |
| Khorrami, A | 2 |
| Jahanban Esfahlan, A | 1 |
| Ghavipanjeh, S | 1 |
| Gholipour Belverdi, M | 1 |
| Darvishani Fikouhi, S | 1 |
| Darbin, A | 1 |
| Najafpour, M | 2 |
| Hirabayashi, S | 1 |
| Yamamoto, K | 2 |
| Nishimura, A | 1 |
| Hosoya, Y | 1 |
| Shuo, T | 1 |
| Kiyokawa, N | 3 |
| Miura, M | 1 |
| Manabe, A | 5 |
| Mizia-Malarz, A | 1 |
| Sobol-Milejska, G | 1 |
| Talebi, M | 1 |
| Bahar Aghdam, S | 1 |
| Mohammadi, H | 1 |
| Karimi Yonjali, S | 1 |
| Asariha, M | 1 |
| Chou, DTS | 1 |
| Taylor, M | 1 |
| Baker, M | 1 |
| Studer, P | 1 |
| Solomon, LB | 1 |
| Aoki, T | 1 |
| Urata, S | 1 |
| Ishihara, D | 1 |
| Umeno, T | 1 |
| Kamimura, T | 1 |
| Li, C | 1 |
| Cai, X | 2 |
| Chen, X | 1 |
| Liang, Y | 2 |
| Xia, Z | 1 |
| Wang, H | 1 |
| Gatineau-Sailliant, S | 1 |
| Buchbinder, N | 1 |
| Callat, MP | 1 |
| Nelken, B | 1 |
| Pautard, B | 1 |
| Vannier, JP | 1 |
| Schneider, P | 5 |
| Esmer, O | 1 |
| Karadag, R | 1 |
| Soylu, E | 1 |
| Oner, AF | 2 |
| Burakgazi-Dalkilic, E | 1 |
| Fichel, F | 1 |
| Eschard, C | 1 |
| Zachar, D | 1 |
| Munzer, M | 4 |
| Bernard, P | 1 |
| Grange, F | 1 |
| Hassan, IB | 1 |
| Kristensen, J | 1 |
| Alizadeh, H | 1 |
| Bernsen, R | 1 |
| Yan, J | 1 |
| Jiang, N | 3 |
| Huang, G | 1 |
| Tay, JL | 1 |
| Lin, B | 1 |
| Bi, C | 1 |
| Koh, GS | 3 |
| Li, Z | 1 |
| Tan, J | 1 |
| Chung, TH | 1 |
| Lu, Y | 1 |
| Ariffin, H | 3 |
| Kham, SK | 4 |
| Yeoh, AE | 4 |
| Chng, WJ | 1 |
| Spijkers-Hagelstein, JA | 4 |
| Pinhanços, SS | 1 |
| Stam, RW | 4 |
| Mei, YY | 1 |
| Gao, C | 1 |
| Cui, L | 1 |
| Zhao, XX | 1 |
| Zhao, W | 1 |
| Li, WJ | 1 |
| Wang, KL | 1 |
| Zhang, RD | 1 |
| Xie, J | 1 |
| Shi, HW | 1 |
| Wang, B | 1 |
| Zhang, YH | 1 |
| Ma, XL | 1 |
| Zhou, X | 1 |
| Wu, MY | 1 |
| Li, ZG | 1 |
| Hyakuna, N | 2 |
| Shimomura, Y | 1 |
| Watanabe, A | 3 |
| Taga, T | 3 |
| Matsushita, T | 2 |
| Kogawa, K | 1 |
| Kawakami, C | 1 |
| Horikoshi, Y | 4 |
| Iwai, T | 1 |
| Okamoto, Y | 2 |
| Tsurusawa, M | 4 |
| Asami, K | 4 |
| Ariës, IM | 2 |
| Hansen, BR | 1 |
| Koch, T | 1 |
| van den Dungen, R | 1 |
| Evans, WE | 7 |
| den Boer, ML | 16 |
| Wang, J | 2 |
| Huang, XJ | 1 |
| Jiang, B | 1 |
| Jiang, Q | 1 |
| Lu, XJ | 1 |
| Xu, LP | 1 |
| Liu, DH | 1 |
| Chen, H | 1 |
| Bao, L | 1 |
| Lu, J | 1 |
| Zhu, HH | 1 |
| Jiang, H | 1 |
| Pinhanços, SM | 1 |
| Garrido Castro, P | 1 |
| Domenech, C | 1 |
| Suciu, S | 4 |
| De Moerloose, B | 2 |
| Mazingue, F | 3 |
| Plat, G | 1 |
| Ferster, A | 3 |
| Uyttebroeck, A | 2 |
| Sirvent, N | 2 |
| Lutz, P | 3 |
| Yakouben, K | 2 |
| Röhrlich, P | 1 |
| Plantaz, D | 3 |
| Millot, F | 2 |
| Philippet, P | 2 |
| Dastugue, N | 1 |
| Girard, S | 1 |
| Cavé, H | 1 |
| Benoit, Y | 3 |
| Bertrandfor, Y | 1 |
| Güneş, AM | 1 |
| Oren, H | 1 |
| Baytan, B | 1 |
| Bengoa, SY | 1 |
| Evim, MS | 1 |
| Gözmen, S | 1 |
| Tüfekçi, O | 1 |
| Karapınar, TH | 1 |
| Irken, G | 1 |
| Koh, K | 4 |
| Tomizawa, D | 1 |
| Moriya Saito, A | 1 |
| Watanabe, T | 2 |
| Miyamura, T | 1 |
| Hirayama, M | 1 |
| Takahashi, Y | 1 |
| Ogawa, A | 1 |
| Kato, K | 1 |
| Sugita, K | 4 |
| Sato, T | 2 |
| Deguchi, T | 2 |
| Hayashi, Y | 4 |
| Takita, J | 2 |
| Takeshita, Y | 1 |
| Mizutani, S | 1 |
| Ishii, E | 4 |
| Bindreither, D | 1 |
| Ecker, S | 1 |
| Gschirr, B | 1 |
| Kofler, A | 1 |
| Kofler, R | 1 |
| Rainer, J | 1 |
| Akaihata, M | 1 |
| Hosoya, M | 1 |
| Brady, V | 1 |
| Thosani, S | 1 |
| Zhou, S | 1 |
| Bassett, R | 1 |
| Busaidy, NL | 1 |
| Lavis, V | 1 |
| Nemes, K | 1 |
| Csóka, M | 1 |
| Nagy, N | 1 |
| Márk, Á | 1 |
| Váradi, Z | 1 |
| Dankó, T | 1 |
| Kovács, G | 2 |
| Kopper, L | 1 |
| Sebestyén, A | 1 |
| van den Dungen, RE | 1 |
| Koudijs, MJ | 1 |
| Cuppen, E | 1 |
| Voest, E | 1 |
| Molenaar, JJ | 1 |
| Caron, HN | 1 |
| Pang, L | 1 |
| Pan, J | 1 |
| Wang, JR | 1 |
| Chai, YH | 1 |
| Zhao, WL | 1 |
| Suzuki, R | 1 |
| Kobayashi, C | 1 |
| Sakai, A | 1 |
| Fukushima, H | 1 |
| Tagawa, M | 1 |
| Satomi, K | 1 |
| Nanmoku, T | 1 |
| Sumazaki, R | 1 |
| Fukushima, T | 4 |
| Paugh, SW | 2 |
| Bonten, EJ | 1 |
| Savic, D | 1 |
| Ramsey, LB | 1 |
| Thierfelder, WE | 1 |
| Gurung, P | 1 |
| Malireddi, RK | 1 |
| Actis, M | 1 |
| Mayasundari, A | 1 |
| Min, J | 1 |
| Coss, DR | 1 |
| Laudermilk, LT | 1 |
| Panetta, JC | 2 |
| McCorkle, JR | 1 |
| Fan, Y | 1 |
| Crews, KR | 1 |
| Stocco, G | 1 |
| Wilkinson, MR | 1 |
| Ferreira, AM | 1 |
| Cheng, C | 4 |
| Yang, W | 4 |
| Karol, SE | 1 |
| Fernandez, CA | 1 |
| Diouf, B | 1 |
| Smith, C | 1 |
| Hicks, JK | 1 |
| Zanut, A | 1 |
| Giordanengo, A | 1 |
| Crona, D | 1 |
| Bianchi, JJ | 1 |
| Holmfeldt, L | 1 |
| Mullighan, CG | 1 |
| Jeha, S | 1 |
| Dunwell, TL | 1 |
| Latif, F | 1 |
| Bhojwani, D | 1 |
| Carroll, WL | 3 |
| Pui, CH | 5 |
| Myers, RM | 1 |
| Guy, RK | 1 |
| Kanneganti, TD | 1 |
| Relling, MV | 4 |
| Liu, L | 1 |
| Qu, Q | 1 |
| Jiao, W | 1 |
| Zhang, Y | 1 |
| Li, X | 1 |
| Ding, C | 1 |
| Wu, D | 2 |
| Kim, DY | 2 |
| Joo, YD | 2 |
| Lim, SN | 2 |
| Kim, SD | 1 |
| Lee, JH | 6 |
| Kim, DH | 1 |
| Kim, K | 1 |
| Jung, CW | 2 |
| Kim, I | 2 |
| Yoon, SS | 1 |
| Park, S | 2 |
| Ahn, JS | 1 |
| Yang, DH | 2 |
| Lee, JJ | 1 |
| Lee, HS | 1 |
| Kim, YS | 1 |
| Mun, YC | 1 |
| Kim, H | 2 |
| Park, JH | 1 |
| Moon, JH | 2 |
| Sohn, SK | 2 |
| Lee, SM | 2 |
| Lee, WS | 2 |
| Kim, KH | 1 |
| Won, JH | 2 |
| Hyun, MS | 2 |
| Park, J | 1 |
| Shin, HJ | 2 |
| Chung, JS | 1 |
| Lee, H | 1 |
| Eom, HS | 2 |
| Lee, GW | 2 |
| Cho, YU | 1 |
| Jang, S | 1 |
| Park, CJ | 1 |
| Chi, HS | 2 |
| Lee, KH | 2 |
| Yun, SC | 1 |
| Ryoo, HM | 1 |
| Bae, SH | 1 |
| Kim, MK | 1 |
| Kim, HJ | 1 |
| Jang, DY | 1 |
| Gordijn, MS | 2 |
| Jones, CL | 1 |
| Gearheart, CM | 1 |
| Fosmire, S | 1 |
| Delgado-Martin, C | 1 |
| Evensen, NA | 1 |
| Bride, K | 1 |
| Waanders, AJ | 1 |
| Pais, F | 1 |
| Bhatla, T | 1 |
| Bitterman, DS | 1 |
| de Rijk, SR | 1 |
| Bourgeois, W | 1 |
| Dandekar, S | 1 |
| Park, E | 1 |
| Burleson, TM | 1 |
| Madhusoodhan, PP | 1 |
| Teachey, DT | 1 |
| Raetz, EA | 1 |
| Hermiston, ML | 1 |
| Müschen, M | 1 |
| Loh, ML | 1 |
| Hunger, SP | 1 |
| Zhang, J | 1 |
| Garabedian, MJ | 1 |
| Porter, CC | 1 |
| Hossain, IT | 1 |
| Moosajee, M | 1 |
| Abou-Rayyah, Y | 1 |
| Pavasovic, V | 1 |
| Takata, H | 1 |
| Ikebe, T | 1 |
| Sasaki, H | 1 |
| Miyazaki, Y | 1 |
| Ohtsuka, E | 1 |
| Saburi, Y | 1 |
| Shirao, K | 1 |
| Yano, M | 1 |
| Asai, D | 1 |
| Suenobu, SI | 1 |
| Hashii, Y | 1 |
| Kawasaki, H | 2 |
| Hori, H | 1 |
| Yumura-Yagi, K | 1 |
| Hagh, MF | 1 |
| Yousefi, B | 1 |
| Rahnama, MA | 1 |
| Heydarabad, MZ | 1 |
| Hallajzadeh, J | 1 |
| Ghahremani, A | 1 |
| Campana, D | 2 |
| Ohara, A | 4 |
| Saito, T | 5 |
| Kikuchi, A | 3 |
| Takahashi, H | 4 |
| Ikuta, K | 5 |
| Hanada, R | 7 |
| Tsuchida, M | 5 |
| Lönnerholm, G | 2 |
| Thörn, I | 2 |
| Sundström, C | 4 |
| Frost, BM | 2 |
| Abrahamsson, J | 1 |
| Behrendtz, M | 1 |
| Heldrup, J | 1 |
| Jacobsson, S | 1 |
| Li, A | 1 |
| Olofsson, T | 1 |
| Porwit, A | 2 |
| Söderhäll, S | 2 |
| Larsson, R | 3 |
| Forestier, E | 2 |
| Bajel, A | 1 |
| George, B | 1 |
| Mathews, V | 1 |
| Viswabandya, A | 1 |
| Kavitha, ML | 1 |
| Srivastava, A | 1 |
| Chandy, M | 1 |
| Figliolia, SL | 1 |
| Oliveira, DT | 2 |
| Pereira, MC | 1 |
| Lauris, JR | 1 |
| Maurício, AR | 1 |
| Mello de Andrea, ML | 1 |
| Nishikawa, T | 1 |
| Kawakami, K | 3 |
| Kumamoto, T | 1 |
| Tonooka, S | 1 |
| Abe, A | 1 |
| Hayasaka, K | 1 |
| Kawano, Y | 1 |
| Papadopoulos, A | 1 |
| Ntaios, G | 1 |
| Kaiafa, G | 1 |
| Girtovitis, F | 1 |
| Saouli, Z | 1 |
| Kontoninas, Z | 1 |
| Diamantidis, MD | 1 |
| Savopoulos, C | 1 |
| Hatzitolios, A | 1 |
| Hulleman, E | 3 |
| Kazemier, KM | 4 |
| Holleman, A | 4 |
| VanderWeele, DJ | 1 |
| Rudin, CM | 1 |
| Broekhuis, MJ | 3 |
| Koharazawa, H | 2 |
| Kanamori, H | 1 |
| Sakai, R | 3 |
| Hashimoto, C | 1 |
| Takemura, S | 1 |
| Hattori, M | 1 |
| Taguchi, J | 2 |
| Tomita, N | 4 |
| Fujita, H | 2 |
| Fujisawa, S | 3 |
| Harano, H | 1 |
| Ogawa, K | 2 |
| Motomura, S | 1 |
| Maruta, A | 3 |
| Ishigatsubo, Y | 2 |
| Pottier, N | 1 |
| Assem, M | 1 |
| Pei, D | 2 |
| Cheok, MH | 3 |
| Goto, H | 2 |
| Naruto, T | 1 |
| Tanoshima, R | 1 |
| Kato, H | 1 |
| Yokosuka, T | 1 |
| Yanagimachi, M | 2 |
| Fujii, H | 1 |
| Yokota, S | 3 |
| Komine, H | 1 |
| Bonney, D | 1 |
| Razali, H | 1 |
| Turner, A | 1 |
| Will, A | 1 |
| Janiszewska, H | 1 |
| Styczynski, J | 6 |
| Kolodziej, B | 2 |
| Wysocki, M | 6 |
| Haus, O | 1 |
| Papathanasiou, C | 1 |
| Papanikolaou, M | 1 |
| Karpusas, M | 1 |
| Zoumakis, E | 1 |
| Tzortzatou-Stathopoulou, F | 2 |
| Sarkar, S | 1 |
| Deb, AR | 1 |
| Saha, K | 1 |
| Das, CS | 1 |
| Basso, G | 1 |
| Veltroni, M | 1 |
| Valsecchi, MG | 1 |
| Dworzak, MN | 1 |
| Ratei, R | 2 |
| Silvestri, D | 1 |
| Benetello, A | 1 |
| Buldini, B | 1 |
| Maglia, O | 1 |
| Masera, G | 1 |
| Conter, V | 1 |
| Arico, M | 1 |
| Biondi, A | 1 |
| Gaipa, G | 1 |
| Saruwatari, H | 1 |
| Yoshifuku, A | 1 |
| Kawai, K | 1 |
| Kanekura, T | 1 |
| Labar, B | 1 |
| Willemze, R | 1 |
| Muus, P | 1 |
| Marie, JP | 1 |
| Fillet, G | 1 |
| Berneman, Z | 1 |
| Jaksic, B | 1 |
| Feremans, W | 1 |
| Bron, D | 1 |
| Sinnige, H | 1 |
| Mistrik, M | 1 |
| Vreugdenhil, G | 1 |
| De Bock, R | 1 |
| Nemet, D | 1 |
| Gilotay, C | 1 |
| Amadori, S | 1 |
| de Witte, T | 1 |
| Bertrand, Y | 3 |
| Robert, A | 2 |
| Margueritte, G | 1 |
| Norton, L | 2 |
| Boutard, P | 2 |
| Baila, L | 1 |
| Otten, J | 2 |
| Isome, K | 1 |
| Matsubara, K | 2 |
| Taki, T | 1 |
| Nigami, H | 1 |
| Yura, K | 1 |
| Iwata, A | 1 |
| Wada, T | 1 |
| Taniwaki, M | 1 |
| Fukaya, T | 1 |
| Elmantaser, M | 1 |
| Stewart, G | 1 |
| Young, D | 1 |
| Duncan, R | 1 |
| Ahmed, SF | 3 |
| Kim, JY | 1 |
| Lee, MY | 1 |
| Kim, B | 1 |
| Park, CW | 1 |
| Chang, YS | 1 |
| Chung, S | 1 |
| Zheng, C | 1 |
| Liu, X | 1 |
| Wu, J | 1 |
| Zhu, W | 1 |
| Sun, Z | 1 |
| Hazar, V | 1 |
| Karasu, GT | 1 |
| Uygun, V | 1 |
| Akcan, M | 1 |
| Küpesiz, A | 1 |
| Yesilipek, A | 1 |
| Collins, L | 1 |
| Zarzabal, LA | 1 |
| Nayiager, T | 1 |
| Pollock, BH | 1 |
| Barr, RD | 1 |
| Flaegstad, T | 1 |
| Heyman, M | 1 |
| Jonsson, OG | 1 |
| Harila-Saari, A | 1 |
| Madsen, HO | 4 |
| Schmiegelow, K | 6 |
| Wesenberg, F | 2 |
| Vettenranta, K | 1 |
| Lim, JY | 1 |
| Chew, FT | 2 |
| Ishida, Y | 1 |
| Mainzer, G | 1 |
| Zaidman, I | 1 |
| Hatib, I | 1 |
| Lorber, A | 1 |
| Suang Lim, JY | 1 |
| Diallo, YL | 1 |
| Diallo, DA | 1 |
| Dembélé, AK | 1 |
| Cissoko, LN | 1 |
| Ly, M | 1 |
| Touré, BA | 1 |
| Teranishi, H | 1 |
| Sakiyama, M | 1 |
| Nagatoshi, Y | 2 |
| Nomura, Y | 1 |
| Inagaki, J | 1 |
| Yanai, F | 4 |
| Okamura, J | 4 |
| Nakagawa, Y | 1 |
| Yamaguchi, R | 1 |
| Suzuki, M | 1 |
| Okada, S | 1 |
| Seckl, JR | 1 |
| Ohzeki, T | 1 |
| Bond, J | 1 |
| Adams, S | 1 |
| Richards, S | 5 |
| Vora, A | 6 |
| Mitchell, C | 4 |
| Goulden, N | 1 |
| Miura, K | 1 |
| Sekine, T | 1 |
| Takamizawa, M | 1 |
| Terashima, H | 1 |
| Furuya, A | 1 |
| Ida, K | 1 |
| Igarashi, T | 1 |
| Krawczuk-Rybak, M | 2 |
| Leszczynska, E | 1 |
| Malinowska, I | 1 |
| Matysiak, M | 1 |
| Ostrowska, H | 1 |
| Chen, SH | 1 |
| Yang, CP | 2 |
| Jaing, TH | 2 |
| Hung, IJ | 3 |
| Shih, LY | 1 |
| Ho, PC | 1 |
| Lee, WI | 1 |
| Huang, JL | 1 |
| de Boer, J | 1 |
| Williams, O | 1 |
| Salzer, WL | 1 |
| Jones, TL | 1 |
| Devidas, M | 1 |
| Hilden, JM | 1 |
| Winick, N | 1 |
| Hunger, S | 1 |
| Camitta, B | 1 |
| Dreyer, ZE | 1 |
| Prickett, TC | 1 |
| Lyver, A | 1 |
| Wilson, R | 1 |
| Espiner, EA | 1 |
| Sullivan, MJ | 1 |
| Oymak, Y | 1 |
| Dodurga, Y | 1 |
| Turedi, A | 1 |
| Yaman, Y | 1 |
| Ozek, G | 1 |
| Carti, O | 1 |
| Gunes, BT | 1 |
| Erbudak, E | 1 |
| Berber, E | 1 |
| Avci, CB | 1 |
| Vergin, C | 1 |
| Chao, YH | 1 |
| Sheu, JN | 1 |
| Chen, SM | 1 |
| Wu, KH | 1 |
| Kuperman, H | 1 |
| Odone Filho, V | 1 |
| Cristofani, LM | 1 |
| Assis de Almeida, MT | 1 |
| Setian, N | 1 |
| Damiani, D | 1 |
| Spenerova, M | 1 |
| Dzubak, P | 1 |
| Srovnal, J | 1 |
| Radova, L | 1 |
| Burianova, R | 1 |
| Konecny, P | 1 |
| Salkova, S | 1 |
| Novak, Z | 2 |
| Pospisilova, D | 2 |
| Stary, J | 2 |
| Blazek, B | 2 |
| Hak, J | 1 |
| Votava, T | 1 |
| Timr, P | 1 |
| Kaiserova, E | 1 |
| Bubanska, E | 1 |
| Mihal, V | 2 |
| Hajduch, M | 2 |
| Piatkowska, M | 1 |
| Jaworska-Posadzy, A | 1 |
| Czyzewski, K | 2 |
| Kubicka, M | 1 |
| Kurylo-Rafinska, B | 1 |
| Debski, R | 1 |
| Pogorzala, M | 1 |
| Mimoso Pinhanços, S | 1 |
| Nakajima, Y | 1 |
| Kuwabara, H | 1 |
| Ohshima, R | 1 |
| Kitagawa, M | 1 |
| Tucker, P | 2 |
| Mushtaq, T | 1 |
| Wallace, AM | 2 |
| Williams, DM | 2 |
| Hughes, IA | 2 |
| Uehara, T | 1 |
| Nakaseko, C | 1 |
| Yokota, A | 1 |
| Saito, Y | 2 |
| Nishimura, M | 4 |
| Hsueh, C | 1 |
| Chiu, CH | 1 |
| Shih, IH | 1 |
| Chan, CK | 1 |
| Seyfarth, J | 2 |
| Nyvold, C | 2 |
| Ryder, LP | 2 |
| Clausen, N | 2 |
| Jonmundsson, GK | 1 |
| Song, A | 1 |
| Dubovy, SR | 1 |
| Berrocal, AM | 1 |
| Murray, T | 1 |
| Alvarez, Y | 1 |
| Coll, MD | 1 |
| Bastida, P | 1 |
| Ortega, JJ | 2 |
| Caballín, MR | 1 |
| Sastry, J | 1 |
| Karandikar, SS | 1 |
| English, MW | 1 |
| Yetgin, S | 5 |
| Tuncer, MA | 1 |
| Cetin, M | 3 |
| Gümrük, F | 3 |
| Yenicesu, I | 1 |
| Tunç, B | 2 |
| Toksoy, H | 1 |
| Koç, A | 1 |
| Aslan, D | 1 |
| Ozyürek, E | 1 |
| Olcay, L | 2 |
| Atahan, L | 2 |
| Tunçbilek, E | 2 |
| Gürgey, A | 3 |
| Petersen, KB | 2 |
| Jusko, WJ | 1 |
| Rasmussen, M | 2 |
| Müller, J | 2 |
| Janka-Schaub, GE | 7 |
| Harms, DO | 1 |
| Gobel, U | 1 |
| Körholz, D | 1 |
| Graubner, U | 1 |
| Haas, RJ | 1 |
| Jorch, N | 1 |
| Spaar, HJ | 1 |
| Kamps, WA | 1 |
| Van der Does-Van den Berg, A | 4 |
| Van Wering, ER | 9 |
| Veerman, AJ | 15 |
| Wiernik, PH | 1 |
| Cassileth, PA | 1 |
| Leong, T | 1 |
| Hoagland, HC | 1 |
| Bennett, JM | 1 |
| Paietta, E | 1 |
| Oken, MM | 1 |
| Matsuda, I | 1 |
| Nakamaki, T | 1 |
| Amaya, H | 1 |
| Kiyosaki, M | 1 |
| Yamada, K | 3 |
| Yokoyama, A | 1 |
| Hino, K | 1 |
| Tomoyasu, S | 1 |
| Bubała, H | 1 |
| Sońta-Jakimczyk, D | 2 |
| Szczepańska, M | 1 |
| Szprynger, K | 1 |
| Tham, CC | 1 |
| Ng, JS | 1 |
| Li, RT | 1 |
| Chik, KW | 2 |
| Lam, DS | 1 |
| Fu, RY | 1 |
| Liao, QK | 1 |
| Jia, CS | 1 |
| Mahachoklertwattana, P | 1 |
| Vilaiyuk, S | 1 |
| Hongeng, S | 1 |
| Okascharoen, C | 1 |
| Hato, A | 1 |
| Minagawa, K | 1 |
| Yakushijin, K | 1 |
| Urahama, N | 1 |
| Sada, A | 1 |
| Okamura, A | 1 |
| Matsui, T | 1 |
| Liu, XG | 1 |
| Chen, SP | 1 |
| Quah, TC | 1 |
| Jakab, Z | 1 |
| Rényi, I | 1 |
| Galántai, I | 1 |
| Békési, A | 1 |
| Kiss, C | 2 |
| Nagy, K | 1 |
| Kajtár, P | 1 |
| Bartyik, K | 1 |
| Masát, P | 1 |
| Magyarosy, E | 1 |
| Roy, A | 2 |
| Bradburn, M | 1 |
| Moorman, AV | 2 |
| Burrett, J | 2 |
| Love, S | 3 |
| Kinsey, SE | 2 |
| Eden, T | 2 |
| Lilleyman, JS | 2 |
| Hann, I | 7 |
| Saha, V | 2 |
| Lugthart, S | 1 |
| Stams, WA | 1 |
| Beverloo, HB | 1 |
| Meijerink, JP | 5 |
| Bhasin, S | 1 |
| Gupta, DK | 1 |
| Kataria, SP | 1 |
| Saluja, S | 1 |
| Sharma, M | 1 |
| van Beek, RD | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| Hakvoort-Cammel, FG | 1 |
| Krenning, EP | 1 |
| van den Heuvel-Eibrink, MM | 1 |
| Hallböök, H | 1 |
| Barbany, G | 1 |
| Aleskog, A | 1 |
| Björnberg, A | 1 |
| Lindhagen, E | 1 |
| Mitchell, CD | 1 |
| Richards, SM | 4 |
| Lilleyman, J | 2 |
| Eden, TO | 1 |
| Cargill, A | 1 |
| Stoneham, S | 1 |
| Lim, A | 1 |
| Darbyshire, PJ | 1 |
| Lancaster, D | 1 |
| Tissing, WJ | 5 |
| Brinkhof, B | 2 |
| van Rossum, EF | 1 |
| Koper, JW | 3 |
| Sonneveld, P | 2 |
| Lauten, M | 1 |
| Igarashi, S | 1 |
| Kumagai, M | 1 |
| Okimoto, Y | 3 |
| Kamijo, T | 1 |
| Isoyama, K | 1 |
| Kajiwara, M | 1 |
| Sotomatsu, M | 1 |
| Maeda, M | 3 |
| Yabe, H | 1 |
| Kinoshita, A | 2 |
| Kaneko, T | 4 |
| Alikasifoglu, A | 1 |
| Tuncer, M | 1 |
| Yordam, N | 1 |
| Irving, JA | 1 |
| Minto, L | 1 |
| Bailey, S | 1 |
| Hall, AG | 1 |
| Rix, M | 1 |
| Birkebaek, NH | 1 |
| Rosthøj, S | 1 |
| Murphy, AJ | 1 |
| Wells, JC | 1 |
| Williams, JE | 1 |
| Fewtrell, MS | 1 |
| Davies, PS | 1 |
| Webb, DK | 1 |
| Ramanujachar, R | 1 |
| Goldstone, A | 1 |
| Rowe, J | 1 |
| Webb, D | 1 |
| Lausen, B | 1 |
| Andreassen, B | 1 |
| Garred, P | 1 |
| Menezes, RX | 2 |
| Ishimoto, K | 2 |
| Shman, TV | 1 |
| Belevtsev, MV | 1 |
| Buglova, SE | 1 |
| Shigematsu, A | 1 |
| Okada, K | 1 |
| Abe, N | 1 |
| Ota, S | 1 |
| Kato, N | 1 |
| Kondo, K | 1 |
| Hige, S | 1 |
| Tanaka, J | 1 |
| Asaka, M | 1 |
| Imamura, M | 1 |
| Pérez Martínez, A | 1 |
| Alonso Ojembarrena, A | 1 |
| Ramírez Orellana, M | 1 |
| García Castro, J | 1 |
| González-Vicent, M | 1 |
| Contra Gómez, T | 1 |
| Madero López, L | 1 |
| Díaz Pérez, MA | 1 |
| Sawicka-Zukowska, M | 1 |
| Kajdas, L | 1 |
| Muszynska-Roslan, K | 1 |
| Szczepanski, T | 1 |
| Miyoshi, I | 1 |
| Kubota, T | 2 |
| Taguchi, H | 2 |
| Swagemakers, S | 1 |
| van der Spek, PJ | 1 |
| Sallan, SE | 2 |
| Armstrong, SA | 1 |
| Yoshimi, A | 1 |
| Taoka, K | 1 |
| Nakasone, H | 1 |
| Iijima, K | 1 |
| Kida, M | 1 |
| Iki, S | 1 |
| Urabe, A | 2 |
| Usuki, K | 2 |
| Sakić, M | 1 |
| Berbić-Fazlagić, J | 1 |
| Kajiwara, R | 1 |
| Kuroki, F | 1 |
| Dundar, B | 1 |
| Eren, E | 1 |
| Oktem, F | 1 |
| Dundar, N | 1 |
| Canatan, D | 1 |
| Krappmann, P | 1 |
| Paulides, M | 1 |
| Stöhr, W | 1 |
| Ittner, E | 1 |
| Plattig, B | 1 |
| Nickel, P | 1 |
| Lackner, H | 1 |
| Schrappe, M | 3 |
| Janka, G | 1 |
| Beck, JD | 1 |
| Langer, T | 1 |
| Lin, WY | 1 |
| Liu, HC | 1 |
| Yeh, TC | 1 |
| Wang, LY | 1 |
| Liang, DC | 2 |
| Kaya, Z | 1 |
| Gursel, T | 1 |
| Bakkaloglu, SA | 1 |
| Kocak, U | 1 |
| Atasever, T | 1 |
| Oktar, SO | 1 |
| Chen, S | 1 |
| Sun, A | 1 |
| Qiu, H | 1 |
| Jin, Z | 1 |
| Tang, X | 1 |
| Miao, M | 1 |
| Fu, Z | 1 |
| Ma, X | 1 |
| Han, Y | 1 |
| Hu, X | 1 |
| Dahl, C | 1 |
| Fuursted, K | 1 |
| Schrøder, H | 1 |
| Sahni, C | 1 |
| Desai, S | 1 |
| Patel, B | 1 |
| Rowe, JM | 1 |
| Goldstone, AH | 1 |
| Fielding, AK | 1 |
| Chawla, B | 1 |
| Agarwal, P | 1 |
| Tandon, R | 1 |
| Titiyal, JS | 1 |
| Felder-Puig, R | 1 |
| Scherzer, C | 1 |
| Baumgartner, M | 1 |
| Ortner, M | 1 |
| Aschenbrenner, C | 1 |
| Bieglmayer, C | 1 |
| Voigtländer, T | 1 |
| Panzer-Grümayer, ER | 1 |
| Steinberger, K | 1 |
| Nasel, C | 1 |
| Gadner, H | 1 |
| Topf, R | 1 |
| Dworzak, M | 1 |
| Bauters, TG | 1 |
| Verlooy, J | 1 |
| Robays, H | 1 |
| Laureys, G | 1 |
| Haarman, EG | 2 |
| Rottier, MM | 2 |
| Matsuzaki, A | 3 |
| Eguchi, H | 3 |
| Yoshida, N | 1 |
| Inoue, T | 1 |
| Miyake, K | 1 |
| Ishihara, T | 1 |
| Tsuboi, C | 1 |
| Bassan, R | 8 |
| Battista, R | 4 |
| Viero, P | 4 |
| Pogliani, E | 5 |
| Rossi, G | 5 |
| Lambertenghi-Deliliers, G | 3 |
| Rambaldi, A | 4 |
| D'Emilio, A | 4 |
| Buelli, M | 4 |
| Borleri, G | 1 |
| Morel, P | 1 |
| Dupriez, B | 1 |
| Herbrecht, R | 2 |
| Bastion, Y | 1 |
| Tilly, H | 1 |
| Delannoy, A | 1 |
| Haioun, C | 1 |
| Nouvel, C | 1 |
| Bouabdallah, K | 1 |
| Baumelou, E | 1 |
| Didcock, E | 1 |
| Davies, HA | 2 |
| Didi, M | 1 |
| Ogilvy Stuart, AL | 1 |
| Wales, JK | 1 |
| Shalet, SM | 1 |
| Bosco, I | 1 |
| Teh, A | 1 |
| al Rajeh, S | 1 |
| Kabiraj, MM | 1 |
| al Fawaz, I | 1 |
| Daif, AK | 1 |
| al Jarallah, A | 1 |
| Slavotinek, A | 1 |
| Thomson, A | 1 |
| Eynaud, P | 1 |
| Perry, P | 1 |
| Steel, CM | 1 |
| Eden, OB | 4 |
| Waits, TM | 1 |
| Greco, FA | 1 |
| Greer, JP | 1 |
| Hainsworth, JD | 1 |
| Van Zantwijk, I | 1 |
| Hählen, K | 6 |
| Kodama, F | 2 |
| Sasaki, S | 1 |
| Fukawa, H | 1 |
| Murata, T | 1 |
| O'Sullivan, EA | 2 |
| Duggal, MS | 2 |
| Bailey, CC | 2 |
| Ohno, R | 3 |
| Scherrer, R | 1 |
| Bettelheim, P | 1 |
| Geissler, K | 1 |
| Jäger, U | 1 |
| Knöbl, P | 1 |
| Kyrle, PA | 1 |
| Laczika, K | 1 |
| Mitterbauer, G | 1 |
| Neumann, E | 1 |
| Schneider, B | 1 |
| Raje, N | 1 |
| Pai, S | 1 |
| Vaidya, S | 1 |
| Gopal, R | 2 |
| Parikh, P | 1 |
| Saikia, T | 1 |
| Pai, V | 1 |
| Nadkarni, K | 1 |
| Advani, IM | 1 |
| Chan-Lam, D | 1 |
| Prentice, AG | 1 |
| Copplestone, JA | 1 |
| Weston, M | 1 |
| Williams, M | 1 |
| Hutton, CW | 1 |
| Vladimirskaia, EB | 1 |
| Zamarraeva, NV | 1 |
| Lebedev, VV | 1 |
| Kryzhanovskiĭ, OI | 1 |
| Rumiantsev, AG | 1 |
| Sallakh, S | 1 |
| Tabet, S | 1 |
| Mazo, IB | 1 |
| Lin, ST | 1 |
| Yang, YM | 1 |
| Chen, HN | 1 |
| Hsieh, YL | 1 |
| Law, KL | 1 |
| Lin, MT | 1 |
| Twu, BH | 1 |
| Charan, VD | 1 |
| Desai, N | 1 |
| Singh, AP | 1 |
| Choudhry, VP | 1 |
| Hata, T | 1 |
| Kuriyama, K | 2 |
| Kawaguchi, Y | 1 |
| Fujimoto, T | 7 |
| Yakata, Y | 1 |
| Saitoh, M | 1 |
| Tsushima, H | 1 |
| Matsuo, Y | 1 |
| Tabata, S | 1 |
| Bessho, F | 2 |
| Kinumaki, H | 2 |
| Kobayashi, M | 1 |
| Kamoshita, S | 1 |
| Masaoka, T | 3 |
| Ogawa, M | 2 |
| Kimura, K | 2 |
| Hamon, MD | 1 |
| Gale, RF | 1 |
| Macdonald, ID | 1 |
| Smith, OP | 1 |
| Collis, CH | 1 |
| Skeggs, DB | 1 |
| Gandhi, L | 1 |
| Prentice, HG | 2 |
| Durrant, IJ | 1 |
| Kubota, M | 2 |
| Adachi, S | 2 |
| Kuwakado, K | 1 |
| Hirota, H | 1 |
| Wakazono, Y | 1 |
| Akiyama, Y | 2 |
| Mikawa, H | 1 |
| Nagura, E | 1 |
| Ota, K | 1 |
| Maekawa, T | 1 |
| Takaku, F | 1 |
| Uchino, H | 1 |
| Amaki, I | 1 |
| Kawashima, K | 1 |
| Hwang, WS | 1 |
| Chen, LM | 1 |
| Huang, SH | 1 |
| Wang, CC | 1 |
| Tseng, MT | 1 |
| Curzon, ME | 1 |
| Hart, P | 1 |
| Mughal, T | 1 |
| Morleda, J | 1 |
| Goldman, J | 1 |
| Fujioka, K | 1 |
| Sumita, H | 1 |
| Sekiguchi, H | 1 |
| Hanzawa, N | 1 |
| Kai, S | 1 |
| Kajigaya, Y | 1 |
| Funabiki, T | 1 |
| Okuyama, T | 1 |
| Yoshida, M | 2 |
| Kurata, H | 1 |
| Tsunoda, S | 1 |
| Iwama, A | 1 |
| Suzuki, T | 2 |
| Akutsu, M | 1 |
| Imagawa, S | 2 |
| Tsunoda, J | 2 |
| Furukawa, Y | 2 |
| Komatsu, N | 2 |
| Ohyashiki, K | 2 |
| Ohyashiki, JH | 2 |
| Toyama, K | 2 |
| Murata, M | 1 |
| Nagai, M | 2 |
| Tasaka, T | 1 |
| Ohnishi, H | 1 |
| Sasaki, K | 2 |
| Taoka, T | 1 |
| Kubota, Y | 1 |
| Tanaka, T | 1 |
| Takahara, J | 1 |
| Kawai, S | 2 |
| Zha, Z | 1 |
| Oka, T | 1 |
| Kaneko, Y | 3 |
| Takaue, Y | 3 |
| Ninomiya, T | 2 |
| Nishikawa, K | 3 |
| Tsuchiya, T | 1 |
| Uemura, K | 1 |
| Otani, H | 1 |
| Sakamoto, K | 1 |
| Sakanishi, Y | 1 |
| Ota, T | 1 |
| Kobayashi, T | 2 |
| Ariyoshi, N | 1 |
| Shirahata, A | 1 |
| Welte, K | 1 |
| Reiter, A | 2 |
| Mempel, K | 1 |
| Pfetsch, M | 1 |
| Schwab, G | 1 |
| Riehm, H | 2 |
| Popp-Snijders, C | 1 |
| Lomecky, M | 1 |
| Van Zantwijk, CH | 6 |
| Swinkels, LM | 1 |
| Soslow, RA | 1 |
| Davis, RE | 1 |
| Warnke, RA | 1 |
| Cleary, ML | 1 |
| Kamel, OW | 1 |
| Brisco, J | 1 |
| Hughes, E | 1 |
| Neoh, SH | 1 |
| Sykes, PJ | 1 |
| Bradstock, K | 1 |
| Enno, A | 1 |
| Szer, J | 1 |
| McCaul, K | 1 |
| Morley, AA | 1 |
| Morland, BJ | 1 |
| Shaw, PJ | 1 |
| Ito, C | 1 |
| McNinch, L | 1 |
| Coustan-Smith, E | 1 |
| Mahmoud, H | 1 |
| Pääkkö, E | 1 |
| Vainionpää, L | 1 |
| Pyhtinen, J | 1 |
| Lanning, M | 1 |
| Di Bona, E | 3 |
| Lerede, T | 4 |
| Rodeghiero, F | 2 |
| Barbui, T | 6 |
| Azuno, Y | 1 |
| Okuya, S | 1 |
| Nakai, K | 1 |
| Nomiyama, J | 1 |
| Mori, K | 1 |
| Okafuji, K | 1 |
| Okubo, M | 1 |
| Matsutani, A | 1 |
| Kamei, S | 1 |
| Zaitsu, Y | 1 |
| Takeuchi, Y | 1 |
| Oka, Y | 1 |
| Kaku, K | 1 |
| Tosi, P | 1 |
| Visani, G | 1 |
| Ottaviani, E | 1 |
| Manfroi, S | 1 |
| Tura, S | 1 |
| Mitsufuji, N | 1 |
| Ikuta, H | 1 |
| Yoshioka, H | 1 |
| Sawada, T | 1 |
| Asano, T | 1 |
| Yamamoto, M | 1 |
| Kuroiwa, A | 1 |
| Yokoyama, Y | 1 |
| Kamoda, F | 1 |
| Shitara, N | 1 |
| Arai, Y | 1 |
| Masuda, M | 1 |
| Okamura, T | 2 |
| Wada, M | 1 |
| Motoji, T | 1 |
| Mizoguchi, H | 2 |
| Urashima, M | 1 |
| Hoshi, Y | 2 |
| Uchiyama, H | 1 |
| Fujisawa, K | 1 |
| Akatsuka, J | 1 |
| Maekawa, K | 1 |
| Hurusato, M | 1 |
| Yamamoto, T | 1 |
| Okubo, T | 1 |
| Ohashi, Y | 1 |
| Minegishi, M | 1 |
| Fujie, H | 1 |
| Tsuchiya, S | 1 |
| Konno, T | 1 |
| Hongo, T | 2 |
| Yajima, S | 2 |
| Sakurai, M | 1 |
| Ono, K | 1 |
| Yoshida, T | 1 |
| Tsuchiya, K | 1 |
| Nakazato, S | 1 |
| Nagumo, F | 1 |
| Shimamoto, Y | 1 |
| Thyss, A | 1 |
| Vilmer, E | 1 |
| Mechinaud, F | 1 |
| Brock, P | 1 |
| Marguerite, G | 1 |
| Plouvier, E | 1 |
| Michel, G | 1 |
| Rialland, X | 1 |
| Chantraine, JM | 1 |
| Solbu, G | 1 |
| Philippe, N | 1 |
| Izzi, T | 3 |
| Corneo, G | 3 |
| Smets, LA | 1 |
| Schuler, D | 1 |
| Szende, B | 1 |
| Yamaguchi, H | 1 |
| Nakamura, H | 1 |
| Mamiya, Y | 1 |
| Yamamoto, Y | 1 |
| Tajika, K | 1 |
| Sugihara, H | 1 |
| Gomi, S | 1 |
| Inokuchi, K | 1 |
| Hasegawa, S | 1 |
| Shibazaki, T | 1 |
| Dan, K | 1 |
| Wakabayashi, I | 1 |
| Tabata, M | 1 |
| Izumi, T | 1 |
| Kawano, C | 1 |
| Kuribara, R | 1 |
| Toshima, M | 1 |
| Omine, K | 1 |
| Takatoku, M | 1 |
| Uchida, M | 1 |
| Kirito, K | 1 |
| Miyazato, A | 1 |
| Hoshino, M | 1 |
| Terui, Y | 1 |
| Tomizuka, H | 1 |
| Otsuki, T | 1 |
| Shimizu, R | 1 |
| Muroi, K | 1 |
| Amemiya, Y | 1 |
| Miura, Y | 1 |
| Yalçin, SS | 1 |
| Ozbek, N | 3 |
| Chessells, J | 1 |
| Hill, F | 3 |
| Bailey, C | 1 |
| Tuncer, AM | 2 |
| Sayli, T | 1 |
| Güler, E | 1 |
| Kara, A | 1 |
| Duru, F | 1 |
| Hann, IM | 1 |
| Hill, FG | 1 |
| Reilly, JJ | 1 |
| Ventham, JC | 1 |
| Ralston, JM | 1 |
| Donaldson, M | 1 |
| Katano, N | 1 |
| Hirota, T | 1 |
| Yanase, T | 1 |
| Koizumi, S | 3 |
| Nakayama, M | 1 |
| Miyawaki, T | 1 |
| Suzumiya, J | 1 |
| Mugisima, H | 1 |
| Hatae, Y | 3 |
| Iwai, A | 2 |
| Anami, K | 1 |
| Kikuchi, M | 1 |
| Osima, K | 1 |
| Kataoka, S | 1 |
| Tanaka, A | 2 |
| Chin, M | 1 |
| Shing, MM | 1 |
| Li, CK | 1 |
| Lam, TK | 1 |
| Lai, HD | 1 |
| Ng, MH | 1 |
| Cheung, AY | 1 |
| Yuen, PM | 1 |
| Hiraoka, A | 1 |
| Sampi, K | 1 |
| Kuraishi, Y | 1 |
| Takemoto, Y | 1 |
| Okabe, K | 1 |
| Tamura, K | 1 |
| Oriani, A | 1 |
| Duyn, AE | 1 |
| Broekema, GJ | 3 |
| Tobinai, K | 2 |
| Shimoyama, M | 1 |
| Mikuni, C | 1 |
| Konda, S | 1 |
| Kozuru, M | 1 |
| Araki, K | 1 |
| Sai, T | 1 |
| Fukuhara, S | 1 |
| Matsumoto, M | 1 |
| Aoki, I | 1 |
| Deura, K | 1 |
| Oyama, A | 1 |
| Hotta, T | 1 |
| Abe, T | 1 |
| Toki, H | 1 |
| Fukuda, H | 1 |
| Niimi, M | 1 |
| Yamaguchi, N | 1 |
| Tajima, K | 1 |
| Shirakawa, S | 1 |
| Nosková, V | 1 |
| Feketová, G | 1 |
| Jess, K | 1 |
| Gojová, L | 1 |
| Kaspárek, I | 1 |
| Hegge, IR | 1 |
| Rots, MG | 2 |
| Jansen, G | 2 |
| Fabris, P | 1 |
| Morandi, S | 1 |
| Casula, P | 1 |
| Vespignani, M | 1 |
| Coser, P | 1 |
| Bueno, J | 1 |
| Zuazu, J | 1 |
| Villalba, T | 1 |
| Julià, A | 1 |
| Kajimoto, H | 1 |
| Naya, M | 1 |
| Hojo, M | 1 |
| Hibi, S | 1 |
| Imashuku, S | 1 |
| Yamada, S | 2 |
| Watanabe, C | 1 |
| Fujii, Y | 1 |
| Yazaki, M | 1 |
| Kinsey, S | 1 |
| Baghdassarian, N | 1 |
| Ffrench, P | 1 |
| Duhaut, P | 1 |
| Bryon, PA | 1 |
| Ffrench, M | 1 |
| Wuchter, C | 1 |
| Karawajew, L | 1 |
| Ruppert, V | 1 |
| Harbott, J | 2 |
| Dörken, B | 1 |
| Ludwig, WD | 2 |
| Huismans, DR | 4 |
| Schuurhuis, GJ | 1 |
| Schwartz, CL | 1 |
| Thompson, EB | 1 |
| Gelber, RD | 1 |
| Young, ML | 1 |
| Chilton, D | 1 |
| Cohen, HJ | 1 |
| Nishihori, Y | 1 |
| Yamauchi, N | 1 |
| Kuribayashi, K | 1 |
| Sato, Y | 1 |
| Morii, K | 1 |
| Hirayama, Y | 1 |
| Sakamaki, S | 1 |
| Honma, H | 1 |
| Suzuki, N | 1 |
| Kudo, T | 1 |
| Niitsu, Y | 1 |
| Harrison, G | 1 |
| Harrison, C | 1 |
| Eden, O | 1 |
| Koga, H | 2 |
| Inada, H | 1 |
| Nibu, K | 1 |
| Tamai, Y | 2 |
| Akiyoshi, K | 2 |
| Nakayama, H | 1 |
| Hara, T | 1 |
| Take, H | 1 |
| Miyazaki, S | 1 |
| Seo, S | 1 |
| Kanda, Y | 1 |
| Shoji, N | 1 |
| Ogasawara, T | 1 |
| Murakami, J | 1 |
| Tanosaki, R | 1 |
| Mineishi, S | 1 |
| Toyoda, Y | 2 |
| Okawa, H | 1 |
| Koike, K | 1 |
| Tsunematsu, Y | 1 |
| Nakazawa, S | 1 |
| Knabe, N | 1 |
| Svejgaard, A | 1 |
| Kuroda, H | 1 |
| Ayukawa, H | 1 |
| Kamizono, J | 1 |
| Kinukawa, N | 1 |
| Lin, YW | 1 |
| Hamahata, K | 1 |
| Nakahata, T | 1 |
| Hatta, Y | 1 |
| Takeuchi, J | 2 |
| Ohshima, T | 2 |
| Horikoshi, A | 1 |
| Iizuka, Y | 1 |
| Kawamura, M | 1 |
| Kanemaru, M | 1 |
| Horie, T | 1 |
| Nakamura, A | 1 |
| Kato, A | 1 |
| Miyake, M | 1 |
| Mimaya, J | 4 |
| Onodera, N | 1 |
| Kanegane, H | 1 |
| Gushi, K | 1 |
| Kawakami, T | 1 |
| Sekine, I | 1 |
| Izichi, O | 1 |
| Okano, A | 1 |
| Shimazaki, C | 1 |
| Ochiai, N | 1 |
| Hatsuse, M | 1 |
| Takahashi, R | 1 |
| Ashihara, E | 1 |
| Inaba, T | 1 |
| Fujita, N | 1 |
| Noda, Y | 1 |
| Nakagawa, M | 1 |
| de Vries, E | 1 |
| Peters, GJ | 1 |
| Creutzig, U | 1 |
| Chen, YC | 1 |
| Ho, CL | 1 |
| Kao, WY | 1 |
| Hwang, JM | 1 |
| Sheu, LF | 1 |
| Chao, TY | 1 |
| Papadopoulou, AL | 1 |
| Moschovi, M | 1 |
| Botsonis, A | 1 |
| Tsangaris, GT | 1 |
| Ramakers-van Woerden, NL | 1 |
| Hoelzer, D | 1 |
| Slater, RM | 1 |
| Loonen, AH | 3 |
| Ossenkoppele, GJ | 1 |
| Vyas, V | 1 |
| Shah, SA | 1 |
| Patel, KM | 1 |
| Parekh, BB | 1 |
| Nath, SV | 1 |
| Hussain, BM | 1 |
| Kyo, T | 1 |
| Naito, K | 1 |
| Sao, H | 1 |
| Takahashi, M | 1 |
| Miyawaki, S | 1 |
| Ohtake, S | 1 |
| Yagasaki, F | 1 |
| Murakami, H | 1 |
| Asou, N | 1 |
| Ino, T | 1 |
| Okamoto, T | 1 |
| Usui, N | 1 |
| Shinagawa, K | 1 |
| Morii, T | 1 |
| Mizuta, S | 1 |
| Akiyama, H | 1 |
| Nakamura, Y | 1 |
| Sweetenham, JW | 1 |
| Mead, GM | 1 |
| Whitehouse, JM | 1 |
| Reid, MM | 1 |
| Saito, H | 2 |
| Damonte, JC | 1 |
| Dufour, P | 1 |
| Maloisel, F | 1 |
| Liu, KL | 1 |
| Ortiz, S | 1 |
| Bergerat, JP | 1 |
| Oberling, F | 1 |
| Imeson, J | 1 |
| Cotterill, S | 1 |
| Gerrard, M | 1 |
| Pinkerton, CR | 1 |
| Isaev, VG | 1 |
| Savchenko, VG | 1 |
| Kucher, RA | 1 |
| Abakumov, EM | 1 |
| Parovichnikova, EN | 1 |
| Jain, AK | 1 |
| Gupta, RC | 1 |
| Bhardwaj, B | 1 |
| Leelani, N | 1 |
| Sasaki, A | 1 |
| Tsukaguchi, M | 1 |
| Musch, E | 1 |
| Malek, M | 1 |
| Peter-Katalinic, J | 1 |
| Egge, H | 1 |
| Rink, H | 1 |
| Lathan, B | 1 |
| Riedel, E | 1 |
| Advani, SH | 1 |
| Iyer, RS | 1 |
| Pai, SK | 1 |
| Saikia, TK | 1 |
| Nair, CN | 1 |
| Kurkure, PA | 1 |
| Nadkarni, KS | 1 |
| Pai, VR | 1 |
| Rohatiner, AZ | 3 |
| Carter, M | 1 |
| MacCallum, P | 1 |
| Amess, J | 3 |
| Maruyama, H | 1 |
| Kawano, K | 1 |
| Uno, H | 1 |
| Matsuoka, H | 1 |
| Yamashita, R | 1 |
| Tamaki, N | 1 |
| Ishizaki, J | 1 |
| Maeda, K | 1 |
| Tsuda, K | 1 |
| Kanamaru, A | 1 |
| Kakishita, E | 1 |
| Nagai, K | 1 |
| Horiuchi, A | 1 |
| Kitani, T | 1 |
| Yasunaga, K | 1 |
| Kawagoe, H | 1 |
| Tatsumi, N | 1 |
| Kageyama, T | 1 |
| Takai, K | 1 |
| Sanada, M | 1 |
| Takeda, T | 3 |
| Utsumi, J | 1 |
| Ohta, S | 1 |
| Philips, GK | 1 |
| Crowell, EB | 1 |
| Mani, A | 1 |
| Volkova, MA | 1 |
| Perilov, AA | 1 |
| Kaletin, GI | 1 |
| Tupitsyn, NN | 1 |
| Frenkel', MA | 1 |
| Fleĭshman, EV | 1 |
| Komiyama, A | 1 |
| Nielsen, SH | 1 |
| Hasselbalch, HC | 1 |
| Birgens, HS | 1 |
| Culbert, SJ | 1 |
| Shuster, JJ | 1 |
| Land, VJ | 1 |
| Wharam, MD | 1 |
| Thomas, PR | 1 |
| Nitschke, R | 1 |
| Pinkel, D | 1 |
| Vietti, TJ | 1 |
| Umeda, M | 1 |
| Shikoshi, K | 1 |
| Anno, S | 1 |
| Su, CY | 1 |
| Shirai, T | 1 |
| Màrky, I | 1 |
| Mellander, L | 1 |
| Lannering, B | 1 |
| Albertsson-Wikland, K | 1 |
| Pinkel', D | 1 |
| Mendeleev, IM | 1 |
| Kovrigina, TI | 1 |
| Polezhaev, IuN | 1 |
| Wakiguchi, H | 1 |
| Fujieda, M | 1 |
| Hisakawa, H | 1 |
| Kubota, H | 1 |
| Matsumoto, K | 1 |
| Kurashige, T | 1 |
| Barnett, MJ | 2 |
| Gregory, W | 2 |
| Lim, J | 2 |
| Oza, A | 2 |
| Horton, M | 2 |
| Henze, G | 1 |
| Fengler, R | 1 |
| Ritter, J | 1 |
| Schunior, A | 2 |
| Zengel, AE | 1 |
| Mullenix, PJ | 2 |
| Tarbell, NJ | 2 |
| Howes, A | 2 |
| Tassinari, MS | 2 |
| Kernan, WJ | 1 |
| Waber, DP | 1 |
| Tonouchi, T | 1 |
| Ueda, R | 1 |
| Kondo, M | 1 |
| Hayashi, S | 1 |
| Nagafuchi, S | 1 |
| Ohtsuka, T | 1 |
| Shibuya, T | 1 |
| Harada, M | 1 |
| Niho, Y | 1 |
| Balázs, M | 1 |
| Kovács, I | 1 |
| Karmazsin, L | 1 |
| Dirven, MW | 1 |
| Heyenbrok, MW | 1 |
| Liu, K | 1 |
| Lobo, AJ | 1 |
| Foster, PN | 1 |
| Burke, DA | 1 |
| Johnston, D | 1 |
| Axon, AT | 1 |
| Digilio, G | 1 |
| Multari, G | 1 |
| Werner, B | 1 |
| Ballati, G | 1 |
| Lemmo, M | 1 |
| Sirignano, A | 1 |
| Iacobini, M | 1 |
| Roggini, M | 1 |
| Cozzi, F | 1 |
| Tanabe, N | 1 |
| Nakura, E | 1 |
| Uzuka, Y | 1 |
| Komatsu, M | 1 |
| Ito, T | 1 |
| Toyota, T | 1 |
| Takahashi, I | 1 |
| Inagaki, N | 1 |
| Nakada, H | 1 |
| Hayashi, N | 1 |
| Sekito, N | 1 |
| Nonaka, K | 1 |
| Takeuchi, M | 1 |
| Osada, K | 1 |
| Matuzaki, T | 1 |
| Fujieda, H | 1 |
| Hojo, H | 1 |
| Baba, Y | 1 |
| Choonara, I | 1 |
| Wheeldon, J | 1 |
| Rayner, P | 1 |
| Blackburn, M | 1 |
| Lewis, I | 1 |
| Cheng, PN | 1 |
| Tso, SC | 1 |
| Chan, TK | 1 |
| Todd, D | 1 |
| Lawton, JW | 1 |
| Ho, FC | 1 |
| O'Connor, NT | 1 |
| Hoffbrand, AV | 1 |
| van Eys, J | 1 |
| Berry, D | 1 |
| Crist, W | 1 |
| Doering, E | 1 |
| Fernbach, D | 1 |
| Pullen, J | 1 |
| Shuster, J | 1 |
| Wharam, M | 1 |
| Yanai, M | 1 |
| Yatabe, M | 1 |
| Utumi, J | 1 |
| Hiyosi, Y | 1 |
| Tanaka, K | 1 |
| Yaoi, K | 1 |
| Moëll, C | 1 |
| Garwicz, S | 1 |
| Westgren, U | 1 |
| Wiebe, T | 1 |
| Gustafsson, G | 1 |
| Kreuger, A | 1 |
| Nakadate, H | 1 |
| Hatayama, Y | 1 |
| Smedmyr, B | 1 |
| Killander, A | 1 |
| Simonsson, B | 1 |
| Javier, G | 1 |
| Olivé, T | 1 |
| Mitani, K | 1 |
| Kobayashi, Y | 1 |
| Kawamura, Y | 1 |
| Yuo, A | 1 |
| Ishikawa, F | 1 |
| Kitamura, T | 1 |
| Ozawa, K | 1 |
| Kitamura, K | 1 |
| Shabalin, VN | 1 |
| Serova, LD | 1 |
| Rozanova, OE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenanc[NCT00003728] | Phase 3 | 1,500 participants (Anticipated) | Interventional | 1998-12-31 | Active, not recruiting | ||
| Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia[NCT00137111] | Phase 3 | 501 participants (Actual) | Interventional | 2000-07-08 | Completed | ||
| Tasigna® (Nilotinib) Plus Multi-Agent Chemotherapy for Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia[NCT00844298] | Phase 2 | 91 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph-positive Acute Lymphoblastic Leukemia[NCT04554459] | Phase 2 | 32 participants (Anticipated) | Interventional | 2021-02-16 | Active, not recruiting | ||
| Treatment Protocol for Newky Diagnosed Adult Ph-Chromosome Positive (BCR::ABL1) Acute Lymphoblastic Leukemia (LALPh2022)[NCT06175702] | 150 participants (Anticipated) | Observational | 2023-12-25 | Not yet recruiting | |||
| A RANDOMIZED PHASE III TRIAL COMPARING DEXAMETHASONE WITH PREDNISONE IN INDUCTION TREATMENT AND BONE MARROW TRANSPLANTATION WITH INTENSIVE MAINTENANCE TREATMENT IN ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL-4)[NCT00002700] | Phase 3 | 392 participants (Anticipated) | Interventional | 1995-08-31 | Completed | ||
| Induction Intensification in Infant ALL: A Children's Oncology Group Study[NCT00002756] | Phase 2 | 221 participants (Actual) | Interventional | 1996-06-30 | Completed | ||
| Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial[NCT00003437] | Phase 3 | 1,800 participants (Anticipated) | Interventional | 1997-01-31 | Active, not recruiting | ||
| Study of Pharmacokinetic Variability of Glucocorticoids in Children[NCT02252237] | 146 participants (Actual) | Observational | 2014-12-03 | Completed | |||
| Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients[NCT02561819] | 25 participants (Anticipated) | Observational | 2015-11-30 | Completed | |||
| Phase III Randomized Trial of Autologous and Allogeneic Stem Cell Transplantation Versus Intensive Conventional Chemotherapy in Acute Lymphoblastic Leukemia in First Remission[NCT00002514] | Phase 3 | 1,929 participants (Actual) | Interventional | 1993-05-07 | Completed | ||
| Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma[NCT00388531] | Phase 2 | 10 participants (Anticipated) | Interventional | 2006-03-31 | Completed | ||
| PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia[NCT00494897] | Phase 4 | 374 participants (Actual) | Interventional | 1996-06-30 | Completed | ||
| Clinical-microbiological Study of Oral Health Condition and Quality of Life of Children/Adolescent With Acute Lymphoid Leukemia and Acute Myeloid[NCT04968860] | 3 participants (Anticipated) | Observational [Patient Registry] | 2019-09-01 | Recruiting | |||
| "Geriatric Assessment Adapted Therapy for Ph- ALL Elderly Patients. GIMEMA Protocol LAL1104. EudraCT Code 2005-002156-17"[NCT00475280] | Phase 2 | 102 participants (Actual) | Interventional | 2007-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"White blood cell (leukocytes) counts in peripheral blood by Complete Blood Count~Measurement: Percentage change of leukemia cells from baseline" (NCT00137111)
Timeframe: Immediately before the methotrexate infusion and three days after subsequent infusion
| Intervention | Percent change (Mean) |
|---|---|
| 4 hr | -44 |
| 24 hr | -50 |
CCR was measured from end of week 56 therapy to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow up time (range) 4.5 (1 to 7.8) years
| Intervention | Percentage of participants (Number) |
|---|---|
| Patients With High Risk of CNS Relapse | 92.2 |
Children were randomly assigned to receive initial single-agent treatment with HDMTX (1g/m^2) as either a 24-hour infusion or a 4-hour infusion and the outcome measure was the accumulation of MTXPG in leukemia cells. (NCT00137111)
Timeframe: 42 hours after start of high dose methotrexate infusion (HDMTX)
| Intervention | pmol/1,000,000,000 cells (Mean) |
|---|---|
| 4 hr | 1688 |
| 24 hr | 2521 |
EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow-up time (range) 5.6 (1.3 to 8.9) years
| Intervention | Percentage of Participants (Number) |
|---|---|
| Total Therapy | 87.3 |
Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of CASP1 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment
| Intervention | arbitrary units (Median) | |
|---|---|---|
| Prednisolone-sensitive cells | Prednisolone-resistant cells | |
| Total Therapy | 341.3 | 447.9 |
Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of NLRP3 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment
| Intervention | arbitrary units (Median) | |
|---|---|---|
| Prednisolone-sensitive cells | Prednisolone-resistant cells | |
| Total Therapy | 41.2 | 110.7 |
Detection of MRD at end of induction where positive MRD was defined as one or more leukemic cell per 10,000 mononuclear bone-marrow cells (>=0.01%). (NCT00137111)
Timeframe: End of Induction (Day 46 MRD measurement)
| Intervention | participants (Number) | |
|---|---|---|
| Negative <0.01% | Positive >= 0.01% | |
| Total Therapy | 390 | 102 |
approximate time: at the recovery of cytopenia (NCT00844298)
Timeframe: 1 month
| Intervention | percentage of analyzable subjects (Number) |
|---|---|
| Nilotinib+mVPD | 91 |
23 reviews available for prednisolone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.
Topics: Atrioventricular Block; Cord Blood Stem Cell Transplantation; Female; Glucocorticoids; Graft vs Host | 2020 |
Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
Topics: Animals; Antineoplastic Agents; Apoptosis; Drug Resistance, Neoplasm; Gene Expression Regulation, Ne | 2020 |
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Flucon | 2017 |
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Glucoc | 2015 |
Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclophosphamide; Da | 2017 |
Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Topics: Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Child; Cohort Studies; Dexamethasone; Glucoc | 2012 |
AML1 amplification in a child with acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromos | 2003 |
[Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Clone Cells; Doxorubicin; Fema | 2003 |
[Results and suggestion from comparing between world excellent protocols of childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Cyclophosphamide; D | 2003 |
Compliance with oral chemotherapy in childhood lymphoblastic leukaemia.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Attitude to Health | 1995 |
[Progress of chemotherapy in adult acute leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daun | 1995 |
Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined M | 1993 |
[Hand-mirror cells acute lymphoblastic leukemia (L3)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Cells; Doxorub | 1995 |
[Chemotherapy of relapsed AML and ALL].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Col | 1996 |
[Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Middle Age | 1996 |
[Recent advances on the treatment of acute childhood leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Disease-Free Surviv | 1997 |
Apoptosis and acute lymphocytic leukemia in children.
Topics: Adolescent; Apoptosis; Child; Child, Preschool; Female; Humans; Male; Precursor Cell Lymphoblastic L | 1997 |
[Relapse of acute lymphoblastic leukemia as a retro-orbital mass].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Methotrexate; Orbital Ne | 1999 |
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; | 2001 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debride | 2001 |
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow T | 2001 |
Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.
Topics: Adult; Blood Proteins; Endocardium; Endomyocardial Fibrosis; Eosinophil Granule Proteins; Eosinophil | 1991 |
[Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia].
Topics: Afibrinogenemia; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fem | 1989 |
70 trials available for prednisolone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated according to Dutch Childhood Oncology Group protocols and its relation to treatment response.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Area Under Curve; Child; Child, Preschool; Female; Huma | 2021 |
Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dexamethasone; | 2014 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administ | 2015 |
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; D | 2015 |
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.
Topics: Adolescent; Animals; Cell Line, Tumor; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; G | 2015 |
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Fem | 2008 |
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dexamethasone; | 2009 |
Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Proto | 2010 |
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced L | 2010 |
Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Dexa | 2010 |
BIM is a prognostic biomarker for early prednisolone response in pediatric acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Bi | 2011 |
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous Sy | 2012 |
Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dexamethasone; Disease-Free Survival; | 2012 |
Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with prednisone or dexamethasone.
Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Antineoplastic Agents, Hormonal; Child; Chi | 2012 |
Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Body Weight; Bone and Bones; Bone Remodel | 2002 |
Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response R | 2003 |
Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
Topics: Administration, Oral; Adolescent; Algorithms; Anti-Inflammatory Agents; Biological Availability; Blo | 2003 |
Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Dexamethasone; Female; Glucocorticoids; Humans | 2003 |
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Grou
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 2003 |
Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.
Topics: Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Antineoplastic Agents, Hormonal; Chi | 2004 |
Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Chil | 2005 |
Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
Topics: Adolescent; Age Factors; Central Nervous System; Child; Child, Preschool; Dexamethasone; Disease-Fre | 2005 |
No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Topics: Child; Child, Preschool; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedu | 2005 |
Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Topics: Adolescent; Adult; Biomarkers; Bone Density; Bone Remodeling; Child; Cross-Sectional Studies; Dose-R | 2005 |
Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells.
Topics: Antineoplastic Agents, Hormonal; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Gene Ex | 2007 |
Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child | 2007 |
High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
Topics: Actuarial Analysis; Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; | 2008 |
Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
Topics: Adolescent; Cell Death; Child; Child Behavior; Child, Preschool; Dexamethasone; Dose-Response Relati | 2007 |
Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 1993 |
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Ch | 1994 |
Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: comparison with previous multicentre German study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asia; Asparaginase; Cytarab | 1995 |
[Treatment for elderly patients with acute non-lymphocytic leukemia].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Da | 1995 |
High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Austria; | 1994 |
Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cran | 1994 |
Treatment of childhood acute lymphoblastic leukemia with protocol TCL-842 in Taiwan: the Taiwan Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1993 |
[A late phase II study of idarubicin hydrochloride in adult patients with acute lymphocytic leukemia. Idarubicin Study Group].
Topics: Adolescent; Adult; Aged; Electrocardiography; Female; Humans; Idarubicin; Male; Middle Aged; Precurs | 1993 |
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1993 |
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1993 |
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1993 |
Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1993 |
Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chi-Square Distribu | 1994 |
[Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1993 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1996 |
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; | 1996 |
Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia.
Topics: Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dose-Response Relationshi | 1996 |
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cost-Benefit Analys | 1997 |
Clinical value of glycated hemoglobin and fructosamine in the long-term glycemic control of children with acute lymphoblastic leukemia.
Topics: Adolescent; Blood Glucose; Child; Child, Preschool; Female; Fructosamine; Glucocorticoids; Glycated | 1998 |
Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1998 |
A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Dose | 1998 |
Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
Topics: Adolescent; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemoth | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkyla | 1998 |
[Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination].
Topics: Adult; Aged; Anorexia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 1999 |
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transpl | 1999 |
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham | 1999 |
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinic
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymph | 1999 |
Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2000 |
Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2000 |
Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
Topics: Blood Cell Count; Bone Marrow Cells; Child; Child, Preschool; Dexamethasone; Dose-Response Relations | 2001 |
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, | 2001 |
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2001 |
Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Female; Follo | 2001 |
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marr | 2002 |
Adult lymphoblastic lymphoma: high incidence of central nervous system relapse in patients treated with the Stanford University protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Neoplasms; Cy | 1992 |
Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantatio | 1992 |
Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; D | 1992 |
Retrospective analysis of late intensification therapy with high-dose methotrexate for standard-risk acute lymphoblastic leukemia in childhood (CCLSG-S811 study). The Children's Cancer and Leukemia Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cranial Irradiation; Humans | 1991 |
Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Follow-Up Stud | 1991 |
[Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Daunorubicin; H | 1991 |
Intensive chemotherapy for acute lymphoblastic leukaemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality T | 1990 |
Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Daunorubicin; | 1990 |
Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1989 |
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc | 1989 |
[Treatment of childhood acute leukemia: a long-term follow-up study of CCLSG-high risk ALL 811 (phase III study). Children's Cancer & Leukemia Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Trials | 1988 |
245 other studies available for prednisolone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.
Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proli | 2021 |
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2022 |
Early and Very Early GRIM19 and MCL1 Expression Are Correlated to Late Acquired Prednisolone Effects in a T-Cell Acute Leukemia Cell Line.
Topics: Apoptosis; Cell Line; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Myeloid Cell Leukemia Seq | 2021 |
Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells.
Topics: Child; Drug Resistance, Neoplasm; Glucocorticoids; Glutamine; Humans; Precursor Cell Lymphoblastic L | 2023 |
Identification of Hub Genes Associated with Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-expression Network Analysis.
Topics: Gene Expression Profiling; Gene Regulatory Networks; Humans; Inflammation; Precursor Cell Lymphoblas | 2023 |
Steroid-induced ocular hypertensive response in pediatric patients with acute lymphoblastic leukemia.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Female; Glaucoma; Glucocorticoids; Humans; Intraoc | 2023 |
Prednisolone Prophase for a Week Versus Upfront Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia: An Analysis With Reference to Induction Mortality in a Developing Country.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Developing Countries; Disease- | 2020 |
Reciprocal Regulation of HSD11B1 and HSD11B2 Predicts Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adolescent | 2020 |
Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Topics: Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytochrome P-45 | 2020 |
Apoptosis Induced by Prednisolone Occurs without Altering the Promoter Methylation of BAX and BCL-2 Genes in Acute Lymphoblastic Leukemia Cells CCRF-CEM.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; DNA Methyl | 2020 |
L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; | 2020 |
Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; | 2020 |
Comparison of myelosuppression using the D-index between children and adolescents/young adults with acute lymphoblastic leukemia during induction chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bac | 2021 |
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Femal | 2021 |
Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacteria; Daunorubicin; Dr | 2017 |
EgoNet identifies differential ego-modules and pathways related to prednisolone resistance in childhood acute lymphoblastic leukemia.
Topics: Child, Preschool; Drug Resistance, Neoplasm; Gene Expression Profiling; Glucocorticoids; Humans; Pre | 2018 |
10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.
Topics: Drug Therapy, Combination; Female; Humans; Imatinib Mesylate; Middle Aged; Precursor Cell Lymphoblas | 2018 |
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 2018 |
Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Epigenesis, Genetic; Gene Expressio | 2018 |
T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host | 2018 |
Paraneoplastic Demyelinating Sensorimotor Neuropathy Delaying the Diagnosis of an Underlying Acute Lymphoblastic Leukemia in a Child.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; D | 2018 |
Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment
Topics: Antineoplastic Agents, Hormonal; Apoptosis; bcl-2-Associated X Protein; Gene Expression Regulation, | 2018 |
Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dasatinib; Down Syndrome; Female; Humans; Phi | 2019 |
NK Cells as Possible Prognostic Factor in Childhood Acute Lymphoblastic Leukemia.
Topics: Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Child; Child, Preschool; Female; H | 2019 |
Regulatory Effect of Resveratrol and Prednisolone on MDR1\
Protein Expression in Acute Lymphoblastic Leukemia Cell\
Line (CCRF-CEM)
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfami | 2019 |
Acetabular avascular necrosis following high-dose steroid treatment and chemotherapy for leukemia : Computer tomography analysis of treatment with impaction bone grafting.
Topics: Acetabulum; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Transplantation; Cure | 2020 |
[Recurring Sweet syndrome in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia].
Topics: Aged; Angina, Unstable; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Percutaneo | 2019 |
Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Cohort Studies; C | 2019 |
[Steroid intake before leukemia diagnosis impairs outcome in childhood acute lymphoblastic leukemia].
Topics: Adolescent; Child; Child, Preschool; Female; Glucocorticoids; Humans; Infant; Male; Precursor Cell L | 2013 |
Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blepharoptosis; Child; Daunorubicin; E | 2013 |
[Kaposiform haemangioendothelioma associated with B-cell acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy | 2013 |
Outcome of patients with acute lymphoblastic leukemia (ALL) following induction therapy with a modified (pulsed dexamethasone rather than continuous prednisone) UKALL XII/ECOG E2993 protocol at Tawam Hospital, United Arab Emirates (UAE).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cancer Care Facilit | 2013 |
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.
Topics: Cell Line, Tumor; Child; Child, Preschool; Computational Biology; Drug Resistance, Neoplasm; Female; | 2013 |
Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.
Topics: Cell Line, Tumor; Chromones; Drug Resistance; Gene Rearrangement; Genomics; Glucocorticoids; Histone | 2014 |
[Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Daunorubicin; D | 2013 |
Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Asian People; C | 2014 |
The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance.
Topics: Antineoplastic Agents, Hormonal; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, N | 2013 |
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; | 2013 |
Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Dose-Response Relationshi | 2014 |
The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2014 |
Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Child, Preschool; Disease-Free Survival; Female; Gene Rearrangement; Hematopo | 2015 |
The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.
Topics: Apoptosis; Child; Dexamethasone; Genes, Neoplasm; Glucocorticoids; Humans; Jurkat Cells; Precursor C | 2014 |
Idiopathic Hyperammonemia That Developed During Initial Treatment With Steroid in a Patient With Newly Diagnosed Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Hydrocortisone; Hype | 2015 |
Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Can | 2014 |
Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool | 2015 |
Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Genes | 2015 |
Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; | 2015 |
Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Child; Female; Hepatitis; Humans | 2015 |
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Base Sequence; Carrier Proteins; Caspase 1; Child; Chil | 2015 |
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, | 2015 |
Orbital mass secondary to infantile acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Infant; Orbital Neoplasms; Precursor | 2016 |
Two Elderly Patients with Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia Who Were Successfully Treated with Dasatinib and Prednisolone.
Topics: Acute Disease; Aged; Dasatinib; Drug Therapy, Combination; Female; Humans; Phenotype; Philadelphia C | 2016 |
IKZF1 deletion is enriched in pediatric B-cell precursor acute lymphoblastic leukemia patients showing prednisolone resistance.
Topics: B-Lymphocytes; Child; Glucocorticoids; Humans; Ikaros Transcription Factor; Precursor Cell Lymphobla | 2016 |
The Effect of Prednisolone on miR 15a and miR16-1 Expression Levels and Apoptosis in Acute Lymphoblastic Leukemia Cell Line: CCRF-CEM.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; MicroRNAs; Precursor Cell Lymphoblastic | 2016 |
Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Blast C | 2008 |
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Hu | 2009 |
Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Pre | 2008 |
Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients.
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplasti | 2008 |
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspar | 2008 |
Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Female; Fibrinolytic Age | 2008 |
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Deoxy | 2009 |
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Child; Child, Preschool; Chromosomal Proteins, N | 2008 |
Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
Topics: Antineoplastic Agents; B-Lymphocytes; Cell Division; Cell Line, Tumor; Cell Survival; Child; Child, | 2009 |
Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Child, Preschool; Co | 2009 |
Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily B; ATP Bind | 2009 |
Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
Topics: Base Sequence; Cell Line, Tumor; Cell Proliferation; DNA Primers; Gene Expression; Humans; Mitogens; | 2009 |
Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.
Topics: Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulati | 2009 |
Simultaneous isolated bilateral facial palsy: a rare vincristine-associated toxicity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Facial Pa | 2009 |
Cutaneous Mycobacterium intracellulare infection in a bone marrow transplantation recipient.
Topics: Bone Marrow Transplantation; Clarithromycin; Graft vs Host Disease; Humans; Immunocompromised Host; | 2010 |
Spinal cord compression by epidural involvement over 21 vertebral levels in acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethas | 2011 |
Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Child; Child | 2010 |
Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Azathioprine; Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hematopoietic | 2010 |
Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2010 |
Growth in children with acute lymphoblastic leukemia during treatment.
Topics: Antineoplastic Agents, Hormonal; Body Mass Index; Child; Child, Preschool; Combined Modality Therapy | 2010 |
In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells | 2011 |
Intrapericardial steroid treatment for recurrent pericardial effusion in a patient with acute lymphoblastic Leukaemia.
Topics: Adolescent; Female; Humans; Injections; Pericardial Effusion; Precursor Cell Lymphoblastic Leukemia- | 2011 |
Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL).
Topics: Biomarkers, Tumor; Cell Line, Tumor; Child; Child, Preschool; Cofilin 1; Disease-Free Survival; Fema | 2011 |
[A case of the association of acute lymphoblastic lymphoma with active tuberculosis in the child: a Malian case].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Ag | 2010 |
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Diseas | 2011 |
Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dexa | 2011 |
Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Clinical Trials as | 2011 |
Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation.
Topics: Bone Marrow Transplantation; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Graft vs | 2012 |
Proteasome chymotrypsin-like activity in plasma as a useful marker for children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Case-Control Studies; Child; Child, | 2012 |
Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Drug Resistance, Neoplasm; | 2012 |
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr | 2012 |
C-type Natriuretic Peptide: a novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL).
Topics: Alkaline Phosphatase; Antineoplastic Agents; Biomarkers; Body Height; Bone and Bones; Bone Developme | 2012 |
Higher expression of the novel gene upregulated gene 4 in two acute lymphoblastic leukemia patients with poor prednisolone response.
Topics: Base Sequence; Child; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Neo | 2012 |
Diagnostic paracentesis in an acute lymphoblastic leukemia child without characteristic symptoms of pancreatitis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Epirubicin; Humans; Male; Pancr | 2013 |
Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Topics: Child; Dexamethasone; Drug Resistance, Neoplasm; Drug Therapy, Combination; Glucocorticoids; Humans; | 2014 |
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Child; Child, Preschool; Daunorubicin; | 2012 |
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Topics: Annexin A2; Benzodioxoles; Cell Proliferation; Drug Resistance, Neoplasm; Gene Rearrangement; Histon | 2013 |
Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Female; Human | 2013 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Trans | 2002 |
Cutaneous lymphocytic vasculitis as the presenting feature of acute lymphoblastic leukemia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Biopsy; Bone Marrow; Child; Humans; Precursor Cell Lym | 2002 |
Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosomes, Hu | 2003 |
Endogenous fungal retinitis in a patient with acute lymphocytic leukemia manifesting as uveitis and optic nerve lesion.
Topics: Antineoplastic Agents; Child, Preschool; Eye Enucleation; Eye Infections, Fungal; Glucocorticoids; H | 2002 |
Benign intracranial hypertension in association with acute lymphoblastic leukemia.
Topics: Acetazolamide; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chlorthalid | 2003 |
Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Topics: Adolescent; Adrenal Glands; Adrenal Insufficiency; Antineoplastic Agents, Hormonal; Antineoplastic A | 2003 |
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Apoptosis; Asparaginase; Caspase 3; Caspases; Child; Daunorubicin; Drug Resis | 2003 |
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combi | 2003 |
[Tumor lysis syndrome in the course of acute lymphoblastic leukemia as the consequence of prednisone monotherapy].
Topics: Adolescent; Anti-Inflammatory Agents; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2003 |
Intraocular pressure profile of a child on a systemic corticosteroid.
Topics: Administration, Oral; Child; Female; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertens | 2004 |
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
Topics: Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; D | 2004 |
An extra X chromosome as a sole abnormality in relapse of an adult acute lymphoblastic leukemia.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Ant | 2004 |
In vitro drug sensitivity and expression profiling for disease prognostication in childhood acute lymphoblastic leukaemia (ALL): an exploratory model using cell lines.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Child; Drug Screening Assays, Antitumor; Gene Exp | 2004 |
[Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham | 2005 |
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
Topics: Age Factors; Antineoplastic Agents; Asparaginase; Cell Survival; Child; Cluster Analysis; Core Bindi | 2005 |
Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Topics: Asparaginase; Cell Survival; Child; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 21; Core B | 2005 |
Chemotherapy-induced palmer planter erythrodysesthesia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Eruptions; Erythema; F | 2005 |
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Body Composition; Bone Density; Child; Child, Pr | 2006 |
In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Agents; Asparaginase; Benzamides; Cell Survival; Cytarabine; Daunorubicin; Dru | 2005 |
Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Co | 2005 |
Alternative medicine remedies might stimulate viability of leukemic cells.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Case-Control Studies; Cat's C | 2006 |
Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
Topics: Base Sequence; Cell Survival; Child; Child, Preschool; DNA Mutational Analysis; DNA, Neoplasm; Drug | 2005 |
Expression of the glucocorticoid receptor and its isoforms in relation to glucocorticoid resistance in childhood acute lymphocytic leukemia.
Topics: Child; Cohort Studies; Drug Resistance, Neoplasm; Gene Expression Regulation; Glucocorticoids; Human | 2005 |
Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course.
Topics: Alleles; Bone Marrow; Cell Line, Tumor; Child; Child, Preschool; Cohort Studies; Exons; Gene Deletio | 2005 |
Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Insufficiency; Antineoplastic Agents, Hormonal; C | 2005 |
Body composition in children in remission from acute lymphoblastic leukemia.
Topics: Absorptiometry, Photon; Adipose Tissue; Body Composition; Body Mass Index; Body Water; Case-Control | 2006 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2007 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2007 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2007 |
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2007 |
Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Topics: Adolescent; Age Factors; Allopurinol; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Pr | 2006 |
Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
Topics: Adolescent; Apoptosis; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Gene Expression R | 2006 |
Moyamoya syndrome following childhood acute lymphoblastic leukemia.
Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cerebral I | 2007 |
Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents, Hormonal; Cell Death; Child; Drug Resistance, Neoplasm; Drug Screening Assays | 2006 |
[Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Asparagine; Child; Child, Preschool; Cyclophospham | 2005 |
Ex vivo activity of thalidomide in childhood acute leukemia.
Topics: Angiogenesis Inhibitors; Cell Cycle; Child; Child, Preschool; Cytarabine; Female; Humans; Immunophen | 2006 |
Non-alcoholic steatohepatitis occurring in a patient with T-lymphoblastic lymphoma during chemotherapy including prednisolone.
Topics: Adult; Antineoplastic Agents; Fatty Liver; Humans; Liver; Lymphoma, T-Cell; Male; Precursor Cell Lym | 2006 |
[Twenty years of treating childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham | 2006 |
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi | 2006 |
Beau's lines after chemotherapy for ALL.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; Humans; Male; Nail | 2007 |
[Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System Neoplasm | 2006 |
[Reults of treatment with protocols BFM 90 and BFM 95].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophospham | 2006 |
Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells.
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Buthionine Sulfoximine; Cell Proliferatio | 2007 |
Hyperosmolar non-ketotic syndrome in a child associated with l-asparaginase and prednisolone.
Topics: Antineoplastic Agents; Asparaginase; Child; Female; Humans; Hyperglycemic Hyperosmolar Nonketotic Co | 2007 |
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implicat
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 2007 |
Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Ch | 2008 |
Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2007 |
A paediatric case of Candida pericarditis and eosophagus stricture during treatment for acute lymphatic leukaemia.
Topics: Antineoplastic Agents; Candida albicans; Candidiasis; Child, Preschool; Doxorubicin; Esophageal Sten | 2007 |
Primary testicular precursor B-lymphoblastic lymphoma: a rare entity.
Topics: Adult; Age Factors; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide | 2007 |
Peripheral ulcerative keratitis with bilateral optic nerve involvement as an initial presentation of acute lymphocytic leukemia in an adult.
Topics: Adult; Corneal Ulcer; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Int | 2009 |
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Humans; Ma | 2008 |
Circumvention of glucocorticoid resistance in childhood leukemia.
Topics: Cell Proliferation; Child; Dexamethasone; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumo | 2008 |
Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1996 |
Pubertal growth in young adult survivors of childhood leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Brain Neoplasms; C | 1995 |
Can cytotoxic drugs cure subacute sclerosing panencephalitis?
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Female; Humans; Precursor Cell | 1995 |
The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1993 |
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Drug Interactions; D | 1995 |
Changes in the oral health of children during treatment for acute lymphoblastic leukaemia.
Topics: Adolescent; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chil | 1994 |
Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Dexamethasone; Humans; Knee Joint; Lymphoma, Non-Hodgkin; Magnetic Resonance Imag | 1994 |
[The effect of polychemotherapy on hemopoiesis in acute lymphoblastic leukemia in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Child, | 1993 |
Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Diabetes Mellitu | 1993 |
[Treatment of acute lymphoblastic leukemia in adults by the modified protocol of L-10M (Sloan-Kettering): long-term outcome].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Fe | 1994 |
Liver function studies in children with acute lymphocytic leukemia after cessation of therapy.
Topics: Adolescent; Adult; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Asparaginas | 1994 |
Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cataract; Cataract Extraction; | 1993 |
Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: failure to detect evidence of apoptosis in vivo.
Topics: Adolescent; Apoptosis; Child; Child, Preschool; DNA Damage; Etoposide; Female; Humans; Leukemia, Mye | 1994 |
Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Col | 1993 |
Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia.
Topics: Adolescent; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined | 1993 |
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co | 1993 |
[Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabin | 1993 |
[Treatment of 71 adult acute lymphoblastic leukemia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 1993 |
[Treatment of adult acute lymphoblastic leukemia with DCVP-l-asp protocol].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 1993 |
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Child; Coloring Agents; Dexamethasone; Drug Screening A | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplati | 1996 |
Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Daunorubicin; | 1996 |
Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Hormonal; Apoptosis; Bone Marrow Cells; Burkitt Lymphoma; Child; | 1996 |
Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; Child, Presc | 1996 |
Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Clo | 1996 |
Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Proto | 1996 |
Lenńox-Gastaut syndrome associated with leukoencephalopathy.
Topics: Adolescent; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; | 1996 |
Acute lymphoblastic leukemia in Ehlers-Danlos syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cytarabine; Disease- | 1996 |
[A case of cerebral aspergillosis associated with induction chemotherapy for acute lymphoblastic leukemia].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Asp | 1996 |
Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Child; Child, Preschool; Cyclophosphamide; D | 1996 |
[Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Co | 1997 |
Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Drug Resistance; Female; Graft vs Hos | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa | 1997 |
A new strategy for treating patients with CD7+, CD4-, CD8- acute lymphoblastic leukaemia.
Topics: Aged; Antigens, CD; Antigens, CD7; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; CD4 | 1997 |
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Blast Crisis; Cell Count; Child; C | 1997 |
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
Topics: Adolescent; Aneuploidy; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspar | 1997 |
Acute lymphoblastic leukemia with isolated adrenocorticotropic hormone deficiency.
Topics: Adrenocorticotropic Hormone; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fatal Outc | 1997 |
[Retrospective analysis of elderly patients > or = 60 years of age with acute leukemia].
Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dau | 1998 |
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Drug Re | 1998 |
Reduced energy expenditure in preobese children treated for acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Energy Metabolism; Fe | 1998 |
Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: preliminary results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child | 1999 |
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia.
Topics: Cell Count; Cell Transformation, Neoplastic; Child; Child, Preschool; Cytarabine; Drug Resistance, N | 1999 |
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Topics: Apoptosis; Bone Marrow Cells; Cells, Cultured; Child; Cytarabine; Dexamethasone; Drug Resistance, Mu | 1999 |
Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
Topics: Adolescent; Antineoplastic Agents; Blast Crisis; Bone Marrow; Cell Line; Child; Dexamethasone; Drug | 1999 |
Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Child; Cryopreservation; Drug Resi | 1999 |
[Acute leukemia in Jehovah's Witnesses].
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; Chri | 1999 |
Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Topics: Adolescent; Asparaginase; Bone Marrow Cells; Cell Culture Techniques; Child; Child, Preschool; Drug | 1999 |
Role of BCL-2 and cell cycle regulatory proteins for corticosensitivity assessment in childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Biomarkers; Cell Division; Child; Child, Preschool; Chromosomes, Human, Pair 11; Chromos | 2000 |
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2000 |
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child | 2000 |
[Severe hemolysis and SIADH-like symptoms induced by vincristine in an ALL patient with liver cirrhosis].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aspar | 2000 |
Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modal | 2001 |
Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Disease-Free Survival; Drug Sc | 2001 |
Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.
Topics: Adolescent; Child; Child, Preschool; Drug Resistance, Neoplasm; Humans; Infant; Neoplasm, Residual; | 2001 |
Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child, Pr | 2001 |
Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Di | 2001 |
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Topics: Amsacrine; Anthracyclines; Antineoplastic Agents; Busulfan; Cell Survival; Child; Child, Preschool; | 2002 |
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow T | 2001 |
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Topics: Adult; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Drug R | 2002 |
Acute lymphocytic leukemia CNS disease presenting as central diabetes insipidus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Chlorambucil; Deamino Arginine Vasopre | 2002 |
Bone marrow examination before steroids in thrombocytopenic purpura or arthritis.
Topics: Arthritis, Juvenile; Bone Marrow Examination; Child; Diagnosis, Differential; Female; Humans; Infant | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamid | 1992 |
[The programmed therapy of acute lymphoblastic leukemia in adults].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclop | 1992 |
Acute lymphoblastic leukaemia presenting as breast mass.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; H | 1992 |
[Evaluation of 58 patients with acute leukemia].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administ | 1992 |
Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.
Topics: Animals; Carcinoma; Chlorambucil; Chromatography, High Pressure Liquid; Colonic Neoplasms; Mammary N | 1992 |
Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Finnish Leukaemia Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; Female | 1992 |
Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: an Indian experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Doxorubicin; Fe | 1992 |
[Acute lymphocytic leukemia (L1) preceded by hypercalcemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Female; Humans; Hypercalcemia; Pr | 1992 |
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
Topics: Antineoplastic Agents; Asparaginase; Chi-Square Distribution; Child; Coloring Agents; Daunorubicin; | 1991 |
[A study of combination chemotherapy (BHAC-ACVP) for adult acute lymphocytic leukemia. Hanshin Co-operative Study Group of Hematological Malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Admi | 1992 |
Prognostic factors and outcome of therapy in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; | 1991 |
[The results of using differentiated programs of therapy in acute lymphoblastic leukemia in adults].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Female; Human | 1991 |
Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia.
Topics: Adult; Antigens, CD; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Protocols; Aspa | 1991 |
[Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; | 1991 |
[Treatment of adult acute lymphoblastic leukemia with Ad-VP-L regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; | 1991 |
A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Weight; Child; Child, Preschool; C | 1991 |
[Treatment of children with acute lymphoblastic leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Ch | 1991 |
[Effects of immunosuppressive chemotherapy on serum levels of IgG subclasses--analysis in children with acute lymphoblastic leukemia and in children with aplastic anemia and autoimmune diseases receiving corticosteroid hormone].
Topics: Anemia, Aplastic; Autoimmune Diseases; Child; Child, Preschool; Humans; Immunoglobulin G; Immunosupp | 1990 |
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; C | 1990 |
An animal model to study toxicity of central nervous system therapy for childhood acute lymphoblastic leukemia: effects on growth and craniofacial proportion.
Topics: Animals; Cephalometry; Combined Modality Therapy; Female; Growth; Humans; Male; Methotrexate; Precur | 1990 |
An animal model to study toxicity of central nervous system therapy for childhood acute lymphoblastic leukemia: effects on behavior.
Topics: Animals; Behavior, Animal; Brain; Cognition Disorders; Combined Modality Therapy; Female; Humans; Ma | 1990 |
Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 11; C | 1990 |
[Transient dysfibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia].
Topics: Adult; Afibrinogenemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubici | 1990 |
Cell membrane fluidity in blast cells of children with acute leukaemia.
Topics: Acute Disease; Blast Crisis; Bone Marrow; Child; Diphenylhexatriene; Fluorescence Polarization; Huma | 1990 |
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
Topics: Asparaginase; Cells, Cultured; Child; Coloring Agents; Culture Media; Cyclophosphamide; Cytarabine; | 1990 |
[Nursing care of leukemia patients in cytolysis syndrome by chemotherapy].
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Huma | 1990 |
The role of azathioprine in the management of ulcerative colitis.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; M | 1990 |
Intestinal obstruction at the onset of acute lymphoblastic leukemia in a child.
Topics: Abdomen, Acute; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Child, Preschool; | 1990 |
[Long-term surviving child with acute lymphoblastic leukemia complicated with legionellosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up Studies; Humans; Legionnair | 1990 |
[Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy].
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosph | 1990 |
[Treatment of acute lymphocytic leukemia in adult].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; | 1989 |
Pharmacokinetics of prednisolone in children with acute lymphoblastic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Half-Life; Humans; | 1989 |
Acute lymphoblastic leukemia in Chinese adults in Hong Kong.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; China; | 1989 |
Prevention of urate nephropathy in the tumour lysis syndrome.
Topics: Adolescent; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Diuresis; Hum | 1989 |
Disturbed pubertal growth in girls treated for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, Preschool; Co | 1987 |
Prognosis after relapse in acute lymphoblastic leukemia in childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cranial Irradiation; Doxo | 1986 |
[BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia].
Topics: Aclarubicin; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 1988 |
Aggressive treatment improves survival in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blood Transfusion; | 1988 |
Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Clinical Protocols; Cytara | 1988 |
[L-asparaginase therapy against hybrid leukemia: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Doxorubicin; Humans; Leukemia, Myeloid | 1988 |
[The action of antitumor preparations on the rosette-forming function of lymphocytes].
Topics: Antineoplastic Agents; Depression, Chemical; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; | 1988 |